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The main goal of this thesis was to 
explore the tableting manufacturing 
sub-processes utilizing chemomet-
rics. In the first part of this study, 
the tablet quality was explored with 
multivariate methods. In the second 
part of this study, multi-way meth-
ods in conjunction with acoustic 
emission data and process variables 
from granulation process of tableting 
material in fluidized bed granula-
tion have been exploited. This thesis 
shows the feasibility and power of 
multivariate data analysis in case of 
evaluation of tablet development and 
manufacturing unit operations.
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ABSTRACT
The aim of this thesis was to explore the potential benefits of chemometric meth-
ods when they are innovatively applied in tableting manufacturing unit operations.
Chemometrics is the application of statistical and mathematical methods, in partic-
ular multivariate methods, to handle chemical or process data. It aims to explore
complex relationships and extract information that is related to the system under
consideration.
In this study, the molecular descriptors with multivariate methods have been
utilized as a potential tool for drug dissolution evaluation from a hydrophobic ma-
trix tablet. In addition, multivariate and multi-way methods in conjunction with
acoustic emission data and process variables from granulation process of tableting
material in fluidized bed granulation have been utilized to enhance process under-
standing. In the granulation process, the best results with the models were achieved
using multi-way methods for modelling of the process data. This was most prob-
ably due to the three-way nature of process data and batch-to-batch variation that
could not be captured using bilinear modelling. This thesis shows the feasibility
and power of multivariate data analysis in case of analysis and evaluation of tablet
development and manufacturing unit operations.
National Library of Medicine Classification: QV 736, QV 778, QV 787
Medical Subject Headings: Technology, Pharmaceutical; Dosage Forms; Tablets;
Multivariate Analysis; Drug Industry; Quality Control
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Matero, Sanni. Kemometristen menetelmien soveltaminen tabletin kehityksessä ja
tuotannossa läpi yksikköoperaatioiden. Itä-Suomen yliopiston julkaisuja. Terveys-
tieteiden tiedekunnan väitöskirjat 16. 2010. 120 p.
TIIVISTELMÄ
Tässä väitöskirjatyössä tutkittiin ja kehitettiin kemometristenmonimuuttujame-
netelmien sovelluksia tabletin valmistusvaiheisiin ja lopputuotteen testaukseen. Ke-
mometria käsitteenä on määritelty olevan kemian osa-alue, jossa käytetään tilasto-
tieteen, matematiikan ja etenkin monimuuttujaisia menetelmiä ratkomaan kemialli-
sia ongelmia. Kemometriset monimuuttuja-analyysit mahdollistavat useidenmuut-
tujien yhtäaikaisen korrelaatio- ja varianssirakenteen hahmottamisen.
Väitöskirjatyössä keskityttiin matriisitabletin formulaatiokehitykseen, rakeis-
tamiseen, suorapuristamisen tabletoinnin optimointiin sekä lääkeaineen vapautu-
miskokeiden ennustamiseen monimuuttujamenetelmin laboratorio-olosuhteissa.
Kaikki nämä tabletin valmistuksen prosessivaiheet ovat olennaisia osia tabletin
valmistusketjussa, tabletin laadun ja toimivuuden varmistamisessa. Tarkoituksena
oli löytää myös uusia prosessiin koskemattomia prosessilinjaa häiritsemättömiä
menetelmiä, joita esimerkiksi lääkefirmat voisivat hyödyntää tutkimuksessaan.
Väitöstyössä sovellettiin uudella tavalla lääkeaineiden molekyylitason tietoa en-
nustamaan lääkeaineen vapautumista tabletista. Lisäksi monimuuttujamenetelmiä
sovellettiin lääke- ja apuaineen rakeistuksen seurantaan. Rakeistusprosessimuuttu-
jina käytettiin muun muassa akustista emissio spektroskopiaa, joka on vielä melko
vähän sovellettu mittausmenetelmä farmasiassa. Rakeistusprosessin aineiston
luonteen vuoksi erityisesti moniulotteisten matriisielementtien (multi-way, engl.)
analyysiin tarkoitetut monimuuttujamenetelmät mallinsivat prosessin parhaiten.
Jokainen tabletin valmistus vaihe raaka-aineesta lopputuotteeksi tulisi tehdä kont-
rolloidusti, jo tablettiformulaation turvallisen käytettävyyden sekä hukkajätteen
vähentämisen vuoksi. Tämä vuoksi prosessien optimointi on tärkeää. Tämä väitös-
kirjatyö osoittaa monimuuttujamenetelmien hyödynnettävyyden tabletin kehitys-
ja valmistusprosessissa.
Yleinen suomalainen asiasanasto: farmasia; tabletit; kehitys; tuotanto; valmistus;
prosessit; optimointi; rakeistus; puristus; lääkeaineet; vapautuminen; tilastomene-
telmät; monimuuttujamenetelmät; lääketeollisuus; laadunvarmistus
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1 INTRODUCTION
Before the year 2001, the use of multivariate methods in pharmaceutical
applications was relatively rare (Gabrielsson et al. 2002). Since USA’s
FDA (Food and Drug Administration) launched its guidance for PAT (pro-
cess analytical technology) for pharmaceutical industry on September 2004
(U.S. Food and Drug Administration 2004), the spectrum of multivari-
ate method applications has been increasing. The objective for FDA was
to encourage manufacturers to innovatively apply and develop new non-
destructive methods and sensors, in a way that information (about the pro-
cess state) would be gathered non-invasively and attained in real-time. The
PAT proposal meant that chemometric multivariate methods became an ac-
ceptable tool for acquiring and analyzing data. Multivariate methods en-
able the analysis of large data sets by extracting the structural part out of
the so-called noise and in the best case scenario, it can transform variable
variation into process related information. Today it is recommended that
all facets of pharmaceutical development should be performed using the
quality by design (QbD) approach which states that quality should be built
within the product rather than tested into a product (ICH Q8(R2) 2009).
The motivation for application of PAT methods in pharmaceutical man-
ufacturing and research has emerged from the extensive amount of re-
sources spent during the years of drug development, from discovering the
molecule to its formulation (Muzzio et al. 2002). The approximate time for a
new drug to be launched from the time it is discovered is 10 to 20 years and
the costs can be as high as 1 billion dollars (780 million euros). Nowadays
fewer and fewer new drugs are in the pipeline (Hughes February 2009)
while the patents on many important drugs already invented are expiring,
thus opening the generic market for these drug products (Shah 2004; Car-
ney 2005; Hughes February 2009). This has placed the drug manufacturers
in the position where their emphasis has switched to manufacture, since
2medicines have to be produced faster andwith fewer resources (Hardy and
Cook 2003; McCormick April 2005; Peterson et al. 2009). Any time-saving
analysis, development or prediction method that helps cut down costs to
achieve a safe and functional drug formulation is welcome. Since PAT
methodology provides process understanding for batch failure or batch-
to-batch variation, it is the method of choice. Moreover, PAT methods can
provide information about differences between raw materials, process con-
ditions, (tableting) unit operations and end product quality.
In this study, multivariate chemometric techniques have been applied in
evaluating a few unit operations in tablet manufacturing. Tablet manufac-
ture is of great interest since tablets are still the most common form of drug
delivery since they have many benefits, namely relatively easy manufac-
ture, oral administration and formulation stability (Varma et al. 2004). The
ideal tablet formulation is a matrix tablet manufactured by direct compres-
sion where drug and excipient powders are mixed and then compressed
directly without the need for any intermediate unit operation. However,
certain demands are placed on the excipient and drug in direct compres-
sion and in many cases, granulation of the powders prior to tableting is
necessary to provide proper tableting properties for the materials.
In tablet manufacturing according to the ideology of FDA’s PAT guid-
ance, every process step of every tablet batch from raw materials to final
product can be considered to take place in a controlled manner. This would
allow the operator to respond to possible defects in the process and correct
the state of the system in order to run the batch pertinently to the end. Thus
the real-time process control is a better indicator of safety for every manu-
factured tablet than random end product testing. The optimized manufac-
ture according to PAT regulations is also environmentally friendly since it
reduces unsuccessful batches and consequently the amount of waste.
In the preface to the book on PAT (Bakeev 2005) edited by Katherine
A. Bakeev she wrote: "A subject as broad as Process Analytical Technol-
ogy (PAT) is difficult to capture in one volume. It can be covered from so
many different angles, covering engineering, analytical chemistry, chemo-
metrics, and plant operations, that one needs to set a perspective and start-
ing point. This book is presented from the perspective of the spectroscopist
who is interested in implementing PAT tools for any number of processes."
3By quoting her words, this thesis is presented from a perspective of the
chemometrician who is interested in implementing PAT tools for a wide
range of tablet related manufacturing processes.
The aim of this work was to study the potential benefits of chemomet-
rics methods when they are innovatively applied for tableting manufactur-
ing sub processes. The molecular descriptors with multivariate methods
have been utilized as potential tools for the evaluation of drug dissolution
from a hydrophobic matrix tablet. Also multivariate and multi-way meth-
ods in conjunction with acoustic emission data and process variables from
granulation process of tableting material in fluidized bed granulation have
been exploited in order to enhance process understanding.
The multivariate methods have been widely exploited in food science,
(petro-) chemical industry, psychology and in environmental science. How-
ever, the literature review of this thesis will consider mainly multivariate
applications in the field of pharmaceutical sciences, mainly studies and ap-
plication for solid dosage forms. Moreover, in the ideal situation, Design
of Experiments (DoE) is one part of process design (Lundstedt et al. 1998).
However, in the real world there are several reasons why it is not utilized
such as 1) lack of knowledge about DoE methods or effective plan of ex-
periments, 2) large number of variables, which should be independent in
design, would lead to a huge amount of measurements, 3) nature of phe-
nomena or historical data, e.g., process data (Wold et al. 2006), which need
to be analyzed 4) collinearity of variables, e.g., in spectral data 5) noise in
data, e.g., acoustic emission spectra In several of the numbered cases, DoE
or effective/intelligent plan of the measurements can be applied. However,
multivariate methods may well be needed to analyze the data.
During the studies there was no possibility to undertake any of those
classical designs (ref. manuscripts III-VI). Instead, in the first (I) and sec-
ond (II) published manuscripts, the self-organizing map approach was
used to perform one kind of design.
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52 CHEMOMETRICS
Chemometrics refers to the application of statistical and mathematical
methods, in particular multivariate methods, to handle chemical or pro-
cess data. The need for chemometrics methods originates from the massive
amounts of data produced by modern measuring devices (Geladi and Es-
bensen 1990; Esbensen and Geladi 1990). Chemometrics tends to deal with
data tables or matrices consisting of several variables (columns of tables or
matrices) and measurement targets (rows or tables or matrices) as a whole
rather than as single variables or means or variations of single variables
(Workman 2002). This multivariate approach enables finding the so-called
latent variables or information of interrelated variables in the original data
matrix which can then be extracted. The latent variable models are based
on the assumption that the original data base dimensionality is not a full
rank (Kourti 2006). The new latent variables are projections of the original
variables on multivariate space. Thus, even the 100 dimensional variable
space can be reduced into a subspace consisting of a few latent variables
that describes underlying phenomena (Bro 2003) such that the originally
100 dimensional space can be visualized. There are several advantages of
using multivariate methods over univariate techniques (Bro 2003) such as
robust modelling, noise removal, handling of interacting variables or over-
lapping spectral profiles, outlier or fault detection (Kourti et al. 1995; Kourti
2006), variable reduction and understanding the reasons for similarity or
dissimilarity of measurements (interpretation plus causality).
Generally, chemometric models have been considered as, even referred
to as soft models since, these models are based on statistics and mathe-
matics of the data rather than the physics or chemistry behind the data
(Martens and Martens 2001). In contrast, the laws of mechanics (Newto-
nian) in physics are considered as hard models since they are fundamental
and can be deployed universally.
6There are several definitions about what is meant by the term chemo-
metrics (Miller 2005) and they have evolved since Professors Svante Wold
and Bruce Kowalski started to apply multivariate methods to handle chem-
ical data around the year 1972 (Wold and Sjöström 1998). According to
Prof. Svante Wold who devised the term "chemometrics", chemometrics
involves mathematical methods as well as the applications of the methods
in problem solving (Wold and Sjöström 1998). The International Chemo-
metrics Society (ICS) defines chemometrics as "the science of relating mea-
surements made on a chemical system or process to the state of the sys-
tem via application of mathematical or statistical methods (Hibbert et al.
2009)." A definition of chemometrics proposed in one of the most impor-
tant chemometrics book is as follows (Massart et al. 1997). "Chemometrics
is a chemical discipline that uses mathematics, statistics and formal logic
a) to design or select optimal experimental procedures; b) to provide max-
imum relevant chemical information by analyzing chemical data; and c) to
obtain knowledge about chemical systems." According to another defini-
tion, chemometrics can be considered as "the application of multivariate,
empirical modelling methods on chemical data" (Miller 2005). In this last
definition, the data-driven empirical modelling, what chemometrics truly
is, rather than theory based is emphasized. However, this does not mean
that chemometrics simply blindly interprets data analysis from any kind of
data. Some knowledge of potential of data acquiring methods on a mea-
surement target based (X matrix) on a phrasing of a question needs to be
available.
Chemometricians have adopted methods from other research fields
such as econometrics and psychometrics where bilinear partial least
squares and multi-way methods, respectively, have been applied and re-
fined (Geladi and Esbensen 1990). Chemometric methods have been
widely applied in the food, biosciences, petroleum, oil and nowadays phar-
maceutical industries, and it is continuing to diverge into new fields such
as metabonomics.
2.1 Methods
Chemometric methods can be categorized in several different ways. There
are clustering, regression and explorative methods. On the other hand,
methods can be separated according to how they explore the data arrays
7u
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Figure 2.1: Illustration of order of arrays for a single sample; one-way, two-
way, three-way, four-way. Adapted from Olivieri (2008).
(Fig. 2.1). A distinction can be drawn between bi-linear, non-linear and
multi-way methods as well as between projection, latent variable and fac-
tor based methods. However, some methods overlap between the above
categorizations. Next, bilinear, multi-way and one neural network meth-
ods, that have been utilized in this thesis, will be introduced.
2.2 Bilinear models
Bilinearitymeans that the system is linear with respect to its decomposition,
i.e. the system is linear in its estimated parameters. In bilinear models,
the data is arranged in data matrices so that each horizontal row contains
samples and each vertical column has variables.
Principal component analysis, PCA, is a linear projection method and
used for reduction of dimensionality and multivariate data compression.
The idea of PCA dates back in 19th century and was named by Hotelling
in 1933 (Smilde et al. 2005; Brereton 2003). At that time, mathematicians
explored multivariate data by fitting it onto lines and planes (Smilde et al.
2005). Today, PCA is one of the vast utilized multivariate method since
its wide applicability for multivariate problems. PCA is deployed for data
compression (Reich 2005) and data exploring within different fields of sci-
ence. PCA is also used for checking groupings of the X data, as well as
grouping among the Y data matrix (Garca-Mu noz et al. 2003; Chiang and
Colegrove 2007). In process monitoring, PCA is used to detect trends, to
find a correlation structure of variables and, in particular, to examine the
changes in variable correlations (Wise and Gallagher 1996; Chiang and
8Colegrove 2007). It should be noted that PCA is feasible for variable re-
duction if variables are correlated and thus contain a similar variance.
Properties of PCA
Principal components are so-called latent variables that are weighted lin-
ear combinations of the original data matrix. A special feature of a latent
variable is that it cannot be measured directly, instead it consists of a linear
combination of measurables, i.e. manifest variables (Martens and Martens
2001). The components are intended to capture the systematic structure of
data and not to describe noise (non-systematic part). The principal compo-
nents are based on the variance of original data matrix, and are extracted by
different approaches, such as eigenvalue or singular value decomposition
or in a sequential manner by using a noniterative partial least squares (NI-
PALS) algorithm. It has been proposed that NIPALS is preferable when the
number of x- variables is large (Kourti 2002). However, the commonality
for all methods is that they find new sets of coordinate axis of the original
data matrix X(I x J) with many objects (I) and variables (J) that are believed
to be correlated and arranges them to orthogonal directions where variance
of the data is maximized. Thus, the PC space is the subspace of the origi-
nal data space X and spans X in lower dimensions. The matrix notation for
PCA is presented as
X = TPT + EF (2.1)
where T(IxF) denotes score matrix, P(JxF) loadings matrix and EF(IxJ)
residual matrix after F components. Eq. 2.1 can be written as vector outer
product, respectively
X = tipTi + ...+ tFp
T
F + EF =
F
∑
i=1
tipTi + EF (2.2)
where i = 1, ..., F and F is the number of latent components (F ≤ I).
The first PC explains the largest part of the variance of the data corre-
sponding to the largest eigenvalue of the eigenvector of the mean centered
XTX covariance matrix. The next component comprises the maximal vari-
ance of the residual data matrix of the first component that corresponds
to the second largest eigenvalue, thus the direction of second largest vari-
ance. The variance explained by a subsequent principal component de-
9creases with increasing order of PC. Since the basic concept of PCA is that
data matrix with many variables is not a full rank and holds a latent struc-
ture that could be explained by a few latent variables, only a small number
of the principal components is needed to explain the maximum variance of
the original data. In the ideal case, the rest of the data contains redundant
data, i.e., noise and error due to the measurement conditions.
Scores and loadings
Principal components consist of scores and loadings as shown in Eqs. 2.1
and 2.2. Most commonly these vectors are plotted because score (Fig. 2.2)
and loading (Fig. 2.3) plots visualize original observations (samples) and
variables in new coordinate systems. The loading values depict how the
original variables are weighted in order to comprise the new axis whereas
the sample scores shows their position in a new coordinate system. These
two plots (Figs. 2.2 and 2.3) are interactive, and thus reasoning for e.g.
clustering of the samples or presence of outliers can be assessed.
Dimensionality
There are several criteria for choosing a dimensionality of a PCA model or
more general, for choosing dimensionality of component models that will
be reviewed in later chapters, such as cross-validation and residuals. One
of these criteria is Kaiser’s rule, in which all PCs with eigenvalues (vari-
ance explained) greater or equal to one should be extracted (de Juan et al.
2004), since PCs having an eigenvalue less than one, as a rule of thumb, are
expected to contain less systematic variation than noise. The other test is
(Cattell’s) scree plot, in which eigenvalues are plotted as a function of the
number of PCs, in descending order. The favourable number of PCs is a
point where the variance explained by individual PC do not differ notably
from subsequent PC (Smilde et al. 2005). Another criteria for choosing
the model dimensionality is a priori knowledge of the data, residual diag-
nostics, cross-validation and statistical diagnostics explained later on this
thesis. The selection of "correct number of PCs" is not essential, if the PCA
models are not utilized for prediction purposes. PCAs applied only in inter-
pretation of data may contain extra PCs as long as the captured information
is seen feasible, and no statistics for residuals, such as for multivariate sta-
tistical process control (MSPC) purposes, is computed out of the model.
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Figure 2.2: Scores plot of objects. The objects are tablets compressed from
eight different drugs, each with three replicates. The data originates from
study II.
Special cases of PCA
The most widely used special cases of PCA are principal component re-
gression (PCR), soft independent modelling of class analogy (SIMCA) and
multi-way principal component analysis (MPCA). PCR is a regression ver-
sion of PCA because it uses the scores of the PCA model to correlate with
the response Y. SIMCA is a clustering method that constructs separate PCA
models for a priori determined class of data. SIMCA operates on the resid-
ual matrix, i.e. distances between model space to test data. It allows an
object to overlap between several classes (Brereton 2003). MPCA operates
with higher dimensional data-array by unfolding it prior to bi-linear PCA.
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Figure 2.3: Loadings plot of variables. The variables are tableting variables
from tablet compaction eight different drugs, each having three replicates.
The data originates from study II.
2.2.1 Partial least squares
Partial least squares (PLS) is a regression method for multivariate data
(Wold et al. 2001). It finds few latent variables from the data X and Y(IxM)
blocks simultaneouslywhilemaximizing the covariance structures between
these two blocks (Wold et al. 2001). PLS is a data decomposition and
compression method since it finds latent, orthogonal directions in the data
blocks at lower dimensions than the original data matrices in such a way
that maximal covariance between X and Y can be achieved (Smilde et al.
2005; Vandeginste et al. 1998). The inventor of the PLS method is Professor
SvanteWold, whomodified the algorithm that was originally developed by
his father, HermanWold, for data analysis purposes in econometrics (Wold
2001; Brereton 2007). One of themathematical notations of PLS is illustrated
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as follows
X = TPT + E (2.3)
Y = UQT + F (2.4)
T = XW (2.5)
U = TD+G (2.6)
where T denotes score matrix, P loadings matrix and E residual matrix
in X space, respectively, and U(IxF) denotes score matrix, Q(MxF) loadings
matrix and F(IxM) residual matrix in Y space, respectively. W(JxF) defines
weight matrix in X space. Eq. 2.6 is commonly named as the inner relation-
ship (D(1xF) rotation matrix and diagonal matrix), since it connects two
different coordinate systems X and Y and G(IxF) is residual matrix of re-
gression. Alternatively the score matrix U in Eq. 2.4 can be replaced by T
and one can neglect Eq. 2.6, thus T becomes the common score matrix of
two spaces (Brereton 2007; Martens 2001). The replacement which simpli-
fied the calculus is allowed since X scores are a good approximation of Y
scores (Wold et al. 2001).
The PLS regression coefficient matrix B for the matrix Y is expressed as
B =W(PTW)−1QT (2.7)
where W denotes weight matrix in X space, i.e. importance of X in re-
gression. TheWweight vectors ofXmatrix are rotated towards theYmatrix
in a way that scores T have maximal covariance with scores U in Y space.
Thus, PLS extracts the common latent structure between X and Y spaces
by also emphasizing the variances of different spaces. The Yhat matrix is
estimated by
Yhat = XB = XW(PTW)−1QT (2.8)
NIPALS
PLS regression solution is attained by least square solution of finding com-
ponents (direction in multivariate space denoted w) that explains the max-
imal variance in the Xmatrix and also correlate the solution to Ymatrix
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max
w
[
cov (t,y) | min
(
I
∑
i=1
J
∑
j=1
(
xij − tiwj
)2)∧ ‖ w ‖= 1] (2.9)
where xhat,ij = tiwj. Most often NIPALS is used to find the solution for
Eq. 2.9. If the common T of Eqs. 2.3 and 2.4 is used, the NIPALS algorithm
finds solutions of PLS1 (with one y variable) as follows (Bro and Elden
2009; Ergon 2009)
1. Let X0 = X. For i=1,2,...,F
2. Compute
wi =
XTi−1y
‖ XTi−1y ‖
(2.10)
3. Compute
ti = Xi−1wi (2.11)
4. Compute
qi =
yTti
tTi ti
(2.12)
5. Compute
pi =
XTi−1ti
tTi ti
(2.13)
6. Deflate the first component
Xi = Xi−1 − tipTi (2.14)
7. Perform steps 2. - 6. until F components is reached and fix estimated
p, q and w to the corresponding matrix. Insert matrices W, P and Q in
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Eq. 2.7 and apply to Eq. 2.8.
As can be seen from the above, PLS is a F-1 component model that is
a subset of the F component model, similarly to PCA, i.e. when the first
set of latent variables is calculated that part of the data can be extracted
from the original data matrices and this is repeated until convergence. It
should be noted that there are different algorithms which can be used to
run PLS, depending on the number of response variables, PLS1 is for one
response variable case and PLS2 for several, correlated response variables,
respectively. It should be also noted that heterogeneity in the data, i.e if
the data consist of distinct groupings, can affect the modelling. If the n re-
sponse variables indicate phenomenally different things, by if one includes
them into the same PLS models tends to count more latent variables than
separately performed PLS models (Wold et al. 2001). This leads to a more
complicated structure and more laborious interpretation.
Properties of PLS
There are advantages associated with PLS and it is thus a widely applied
multivariate regression method. PLS is capable of handling collinear vari-
ables, such as spectral data and it is capable to handle ill-conditioned ma-
trices (by using latent variables). PLS can also handle missing data to some
extent which is an appealing property, for instance if one needs to process
data where some probes may be malfunctioning or data from a certain day
is missing. The method also assumes that there is noise present both in X
and Y measurements which is lacking in an ordinary regression, such as
MLR (multiple linear regression) (Brereton 2003, 2007). In general, the PLS
method is applicable for any kind of multivariate regression problem, and
is often the initial method of choice.
One special modification of PLS is PLS-DA (partial least squares dis-
criminant analysis), where the X matrix is regressed into a dummy matrix
consisting of zeros and ones indicating the class to which the samples be-
long and this has been done using the PLS algorithm.
2.3 Multi-way models
Multi-way models are used when the data is multivariate and linear in
more than two dimensions. These can be considered to devise a model
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in n-dimensions so that the system is linear in n dimensions. A three-linear
system is often visualized as a data cube and is called a 3-way data or 3-
way array whereas bilinear system is a rectangular matrix that can be con-
sidered as 2-way data. For instance, three-way array can be created out
of data of different batch runs, samples with variables in two dimensions,
like fluorescence measurements and measurements acquired from different
locations (Bro 1996; Smilde et al. 2005). Simply put, if the data from one
sample forms a matrix, then data from several samples can be set in a box
that is a three-way array (Bro 2003).
The multi-way modelling originated from psychological data treat-
ment where bilinear data analyzing methods were not adequate (Smilde
et al. 2005). These multi-way models have proven to be useful multi-way
data handling methods for extracting chemically relevant information from
spectra (Bro 2006), e.g. enhancing chemical understanding and evaluating
relative concentrations of compounds in a sample (Bro 1998; Geladi and
Forsstrom 2002; Andersen and Bro 2003). Multi-way methods have also
been applied to process control as well as in regression analyses (Smilde
et al. 2005; Andersen and Bro 2003; Bro 1999).
2.3.1 Parallel Factor Analysis, PARAFAC
Parallel factor analysis (PARAFAC) is a decomposition method for mod-
elling three-way or higher data introduced independently by Harshman
(1970) and Carroll and Chang (1970) (Smilde et al. 2005; Bro 1998, 1997).
PARAFAC is a generalisation of the principal component analysis (PCA)
projectionmethod for a multi-way array. The data is decomposed into three
linearly related matrices which describe the most important variation of the
data matrix with the same factors, which is depicted in Fig 2.4.
The mathematical notation of a trilinear PARAFACmodel is depicted as
Xk = ADkBT + Ek, k = 1, ...,R (2.15)
where Xk(IxJxK) is a matrix containing the original data of dimensions,
A(IxR) the loadings for sample mode, B(JxR) the loadings of the variable
mode, D weights or relative contribution of loadings of A and B (loadings
C(KxR) of the third mode are in diagonal of D) and Ek(IxJxK) the residual
term not related to the model. The PARAFAC model may alternatively be
expressed (Smilde et al. 2005) element-wise of the Xk matrix as follows
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Figure 2.4: A graphical illustration of a two-component PARAFAC model.
xijk =
R
∑
r=1
airbjrckr + eijk (2.16)
whereR is the number of PARAFAC components. The PARAFACmodel
(i.e. loadings A, B and C) can be estimated iteratively utilizing the alternat-
ing least squares (ALS) by minimizing the residual sums of squares (Bro
1997). First, R is determined. An initial approximation for matrices B and C
is then given, and A loadings are estimated from Xk, B and C. Thereupon B
and C are estimated, respectively, and the iteration from A to C starts over
again until convergence is achieved, i.e. fit of the loadings are sufficiently
stable (Bro 1997).
The PARAFAC model has a second-order advantage, i.e. it can han-
dle interferents in new samples by fitting the new interferent with an extra
component (Rinnan et al. 2007; Bro 2003). For instance, if three-way data
consists of three chemical constituents and one interferent, a four compo-
nent PARAFACmodel is anticipated. The estimated PARAFAC loadings for
each of the modes are relative amounts for each component, however, the
model can be utilized for calibration, if at least one sample concentration or
other response value is known (Rinnan et al. 2007).
PARAFAC is not a sequential algorithm, where a R-1 component model
is a subset of the R component model, since loadings do not have to be or-
thogonally decomposed (Bro 1998). Each PARAFAC model is unique and
not related to other models that have different amounts of components,
hence the effect of the number of components differs from PCA. PARAFAC
loadings cannot be rotated like principal components, without affecting the
model fit (Bro 1997). It should be noted that PARAFAC components are
17
not forced to be orthogonal which is a useful feature when modelling spec-
troscopic data and finding the true estimates for parameters of the data.
Different constraints which are present prior to modelling can be imposed
for loading matrices, such as non-negativity which may be adequate for
spectral data and unimodality e.g. for chromatographic data. Constraints
can help interpretability of the model and assist in obtaining realistic model
loadings (Andersen and Bro 2003).
2.3.2 Tucker3
The Tucker3 method can be used for compression and data exploration of
N-way array (Smilde et al. 2005). The Tucker3 model consists of loading
matrices in n modes, factors that are typically orthogonal and a (P, Q, R)-
dimensional core array G. The mathematical notation of Tucker3 model is
illustrated in Eq. 2.17
Xk = AG
(
C | ⊗ | BT
)
+ Ek, (2.17)
where Xk(IxJxK) stands for an original data array, G(QxPxR) is a core
array with dimensions of chemical ranks of modes and weights of different
loadings A(IxP), B(JxQ) and C(KxR) are the loading matrices of the first,
second and the third modes, respectively, | ⊗ | the Khatri-Rao product and
Ek(IxJxK) the residual matrix. The core array encompasses the inherent in-
teractions of different loadings and provides an approximation of the vari-
ation of Xk (Bro 1998). The core elements reveal the importance of respec-
tive factor combinations for the model Xk. The Tucker3 core array differs
from the PARAFAC core by having at least one off-diagonal core element
as non-zero, whereas the PARAFAC has a so-called superdiagonal core ar-
ray (Bro 1998) and thus PARAFAC can be considered as a special case of
the Tucker3 model (Smilde 2001). This Tucker3 core array has the abil-
ity to fit variation in data more efficiently. It is noteworthy that different
modes may exhibit different numbers of components in the Tucker3 model
whereas in PARAFAC that is not the case. Moreover, Tucker3 is often used
as a compensatory method for PARAFAC. If two or one modes of Tucker3
model only need to be compressed, the models are then called Tucker2 and
Tucker1 models, respectively. Let i, j, k be the modes for 3-way Xk data
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xijk =
P
∑
p=1
Q
∑
q=1
aipbjqgpqk + eijk, (2.18)
xijk =
P
∑
p=1
aipgpjk + eijk, (2.19)
Westerhuis et al. (1999) illustrated that the Tucker1 model is a feasible
method to model batch data where Tucker1 core array exhibits specifically
the interactions of time and variable modes in between the interactions are
frequently presented. However, it is case-specific which of the multi-way
models work best for batch data and no general conclusions can be drawn
(Smilde 2001).
2.3.3 Parallel Factor Analysis 2, PARAFAC 2
PARAFAC2 is intended also for modelling N-way data but, in contrast to
PARAFAC, it handles experiments of different lengths and variable profiles
that are shifted or in a different phase (Smilde et al. 2005; Bro et al. 1999;
Kiers et al. 1999). The PARAFAC2 model is similar to the PARAFAC model
except that the loading matrix Bk that has k dimensions and it needs to
fulfil the conditions of covariance equality BT1B1 = ... = B
T
k Bk (Bro 1998).
This condition is more flexible than in PARAFAC, where profiles of slabs
(e.g. B1 = B2 = ... = Bk) must be of equal size (Bro 1998). PARAFAC2
enables trilinearity not to be fulfilled in one mode, whereas in PARAFAC
trilinearity is a fundamental condition. However, it should be noted that
also PARFAC may fit non-linearity to some extent in one mode but in cases
when data shifts from linearity are regular.
2.3.4 N-partial least squares, N-PLS
N-PLS is an extension of the PLS algorithm for multi-way data (Bro 1998,
1996). The main principles are similar to the bilinear PLS algorithm, i.e.,
N-PLS uses also dependent and independent variables for finding the la-
tent variables to describe their pairwise maximal covariance. N-PLS is a se-
quential algorithm like PLS. Thus, the F-1 component model is a subset of
the F component model. N-PLS decomposition starts by constructing a dis-
tinct PARAFAC like model for dependent response variables (Yk(IxMxK))
and for descriptor variables (Xk(IxJxK)) and maximizing the covariance be-
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tween these two matrices. The mathematical notation of N-PLS calibration
model can be written as
Xk = T(WK | ⊗ |WJ)T + EXk, (2.20)
Yk = U(QM | ⊗ | QL)T + EYk, (2.21)
U = TB+ Eu, (2.22)
wherematricesT andU include score vectors of the original data,W and
Q weight vectors, residual terms, B regression coefficients and EXk(IxJxK)
and EYk(IxJxK) the residual matrices. N-PLS methods, like all multilinear
methods, are simpler than models that need unfolding (or matricizing),
since multilinear models have less loading elements which need to be con-
structed (Bro 1996). However, N-way PLS is more restricted compared to
its unfolded counterpart, since the N-linearity of the X matrix needs to be
fulfilled. It should be noted that N-PLS does not have second-order advan-
tage (Olivieri 2008).
2.3.5 Advantages of multi-way methods
Some of the advantages of multi-way models are that they have been rec-
ognized as useful tools for monitoring batch data since they improve the
understanding of the process and summarize its behavior in a batchwise
manner (Wise et al. 2001; Smilde 2001). These kinds of approaches, such
as multiway principal component analysis (MPCA) and multiway partial
least squares (MPLS), have been successfully used for this purpose (Kourti
2003a,b). The MPCA and MPLS methods require that one obtains a N-way
data array containing information from several batches to be unfolded, i.e.,
transformed in matrices which are suitable for analysis by PCA or PLS.
One limitation is that the models computed from unfolded data are often
difficult to interpret, if the original data contains higher dimensions. There-
fore, multi-way methods that work with three-way or higher arrays are the
methods of choice. Usually these multi-way models find less loading ele-
ments to fit for one component compared to the bilinear models, e.g. MPCA
and MPLS and thus the interpretation of correlation structure of variables
and objects can be made in a more straightforward manner.
Methods like parallel factor analysis (PARAFAC and PARAFAC2) com-
prise the factor models by preserving the common variation of the original
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data in every dimension (Smilde et al. 2005; Bro et al. 1999; Kiers et al.
1999). The assumption on which these models is based is that every di-
mension includes similar information, i.e. a latent structure but with dif-
ferent amounts for individual experiments (Bro et al. 2008). For instance,
for batch data, this property allows one to define in detail the differences
in structure between well and badly performed batches by evaluating the
process outcome. PARAFAC is mainly intended for data having congru-
ent variable profiles within each batch, whereas PARAFAC2 can handle
data with different temporal durations and variable profiles. PARAFAC as
well as PARAFAC2 have been mainly applied for analyzing chemical data
from experiments that form a 3-way or higher data structure, e.g. chro-
matographic data, fluorescence spectroscopy measurements, temporal var-
ied spectroscopy data with overlapping spectral profiles (Bro 2006; Ander-
sen and Bro 2003) and process data (Meng et al. 2003; Wise et al. 2001; Bro
1999). The advantage of multi-way models in analysing spectral data is
their ability to determine the compound composition of a mixture, which
is often a demanding task due to overlapping and other problems typi-
cally present in spectral data (Jiji et al. 1999; Moberg et al. 2001). These
multi-waymodels have proven to be useful multi-way data handlingmeth-
ods for extracting chemically relevant information from spectra (Bro 2006),
e.g., enhancing chemical understanding and evaluating relative concentra-
tions of compounds in a sample (Bro 1998; Stedmon et al. 2003; Andersen
and Bro 2003; Geladi and Forsstrom 2002). Multi-way methods have also
been applied to process control procedures as well as in regression analyses
(Smilde et al. 2005; Andersen and Bro 2003; Bro 1999).
It should be noted that utilization of multi-way models in problem solv-
ing has been on the increase in recent years (Bro 2006), most probably be-
cause of the increased awareness of the potential advantages of these multi-
way methods.
2.4 Neural networks
Neural networks are widely applied in pattern recognition and classifica-
tion tasks (Agatonovic-Kustrin and Beresford 2000; Zupan and Gasteiger
1999). The neural network mimics the human brain containing neurons
that are mathematical entities interrelated to other neurons and working
according to the functions of each neuron (Agatonovic-Kustrin and Beres-
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ford 2000). The detailed structure of the neural network differ depending
the application but the main principles are somewhat similar (Zupan and
Gasteiger 1999). Neural nets are shortly described in this thesis because of
their occasional utilization in this context.
2.4.1 Tree-structured self-organizing maps (TS-SOM)
TS-SOM (Koikkalainen 1994) as implemented in Visual Data (Visipoint
2003) is a modified version of Kohonen’s unsupervised Self - Organiz-
ing Map (Kohonen 2001), that has an ability to represent high dimen-
sional data in lower dimensions, i.e. 2-dimensional lattice. The lattice
consists of neurons that describe the weight vector of original variables,
(ws = ws1+ws2+ ...+wsj) of each neurons s. Since SOM is an unsupervised
learning method, it "learns" the data and performs the grouping based on
weight vector similarity of the data objects. In the TS-SOM, ordinary SOMs
are organized hierarchically and at every level, the size of the SOM is four
times greater than at a previous level. In addition to the TS-SOM, the neigh-
bourhood function of the Best-Matching Unit (BMU) neuron is connected
to four adjacent neurons. The BMU is the winning neuron where Euclidean
distance between the input data object vector xi and the respective weight
vector wm is the smallest:
c(xi,W) = argmin
j
‖xi − wj‖, (2.23)
whereW present weight vectors of SOM (Kolehmainen 2004).
After defining the BMU, theweight vectors of respective and neighbour-
ing neurons are corrected in order to represent the weights of the prevailing
mapping.
The neighbourhood neurons contain objects having more similar prop-
erties. Thus the SOM algorithm creates regions containing the same kind of
information. The basic idea behind the SOM is that with this iteration and
self- learning it can create a feature map that is a good approximation of the
initial data space (Kohonen 2001). Due to the neighbourhood function cri-
terion and the hierarchical structuring, TS-SOM is a more efficient tool for
handling massive data sets than the ordinary SOMs (Kolehmainen 2004).
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2.5 Pre-processing
Pre-processing refers data transformation prior analysis, i.e., weighing the
original data differently, removing non-linearity, handling data so that it
becomes more suitable for analysis (Vandeginste et al. 1998) and/or it can
decrease themodel complexity (Rinnan et al. 2009). Usually, it is performed
in a variable-wise manner since the most common operations are run in col-
umn space. Most commonly pre-processing method for data is called mean
centering to unit variance and is the default option in some software pack-
ages, such as SIMCA-P. However more advanced and other pre-processing
routines need to be taken into account e.g. with spectral, noisy and pro-
cess data. The following pre-processing operations are presented mainly in
the column space of a two-way matrix. However, sometimes raw data is
handled without any pre-processing (Sekulic et al. 1998).
2.5.1 (Mean) Centering
Centering is applied for data including offsets (Bro and Smilde 2003) since
the purpose of centering is to remove this feature. This action may reduce
the rank of the truncated, model matrix (Bro and Smilde 2003). Center-
ing is applied across the first mode, i.e. subtracting column average from
elements of matrix or across the second mode, i.e. by subtracting the row
average, respectively (Bro and Smilde 2003). Mean centering of variables is
achieved by subtracting each column in the matrix by its mean value (Van-
deginste et al. 1998).
zij = xij −mj = xij − 1I
I
∑
i
xij (2.24)
z stands for the transformed elements of data matrix after mean center-
ing, x for the elements of original data matrix, m for mean (vai average) of
the column. The column vectors of transformed matrix Z have zero mean.
In the case of a multi-way array, centering across one mode, i.e. single-
centering is carried out by first unfolding the data matrix then subtract-
ing the offset and folding the array. If centering is to be performed in two
modes (double-centering), centering is accomplished one mode at a time,
hence, first one mode is to be unfolded and centered column-wise followed
by centering of the other mode.
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It is noted that centering refers to projection onto nullspace of 1T (Bro
and Smilde 2003). Therefore data matrix is moved in the direction of off-
set and the offset is thus removed. Centering changes the structure of the
model (Bro and Smilde 2003). Centering, with process data, can be also
subtracting set points instead of the mean value (Wold et al. 2001).
2.5.2 Scaling
Scaling is used for data with variables of different magnitudes (Bro and
Smilde 2003), i.e., variables from different sources. The scaling involves
the rows or columns to be multiplied by a scalar value, mostly this will be
the inverse of the standard deviation. The row-wise scaling is preferred
as scaling within the first mode whereas column-wise scaling is preferred
within the second mode, respectively (Bro and Smilde 2003).
sj =
√√√√∑Jj=1(xij −mj)2
J − 1 ; (2.25)
zij =
xij −mj
sj
; (2.26)
where sj is standard deviation zij stands for the transformed the ele-
ments of data matrix after scaling, x for the elements for original data ma-
trix, m for the mean of the column. The column vectors of transformed
matrix Z have zero mean. The scaling of multi-way array is implemented
in a slab-wise manner, after unfolding of the data (Bro and Smilde 2003).
Scaling to unit variance or column-standardization or autoscaling (Bro
and Smilde 2003) is a commonly utilized method for pre-processing (Van-
deginste et al. 1998) and it is typically applied when lacking prior informa-
tion of the importance of variables relative to the model (Wold et al. 2001).
Applying the scaling to data to a unity allows an equal weight of every
variable for model fitting. Scaling does not affect the structure of the model
and has a less dramatic influence on the model (Bro and Smilde 2003).
2.5.3 Partial weighting of variables
Partial weighting of variables can be considered as a special case of variable
scaling. In order to achieve similar variance by ranking the importance of
data points, scaling of less important part of the data is applied. If data is
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acquired with different methods from the same measuring target but of un-
equal sizes (multi-block data) (Bro and Smilde 2003) or if some part of data
is more relevant for the specific problem such as fault diagnostics in pro-
cess chemometrics (Kourti 2006; Kourti et al. 1995), then partial weighing
of data points may be used. In process monitoring for instance, some vari-
ables are under tighter control than others and if these variables indicate
the fault occurrence they need to be highlighted in order to contribute to
the first latent components for fault diagnostics (Kourti 2006). In addition,
if some variables are known to contribute to the quality significantly they
could be weighted by two-fold or so (Kourti 2002).
2.5.4 Variable or subset selection
A variable or subset selection is one of the most widely studied topics
in chemometrics. Dimension reduction of an original data table prior to
multivariate modelling becomes essential when hundreds or thousands of
variables are used for understanding or defining the present data structure
(Willighagen et al. 2006). The idea of variable selection is to extract variables
that do not contribute to the latent structure of the data (Höskuldsson 1996,
2001, 2003) and also to find, on the contrary, those variables that contribute
to the best or most stable latent structure. Thus, the variable selection en-
ables easier interpretation of the most important variables which modify
the modelling output.
There are many different methods from which to select the most im-
portant variables for regression or classification problems such as classi-
cal forward and backward selection, interval partial least squares (iPLS)
(Norgaard et al. 2000), genetic algorithm (GA) (Leardi and Norgaard 2004),
covariance procedures (CovProc) (Reinikainen and Hoskuldsson 2003) to
name a few. In SIMCA-P software, a special VIP (variable importance on
projection) is used to select the most important variables that contribute to
the model. Also weight vectors (with some possible cut-off value) can be
used as the basis for the selection in some approaches, such as CovProc.
2.6 Model validation
Performance of the model to predict the future samples and to describe
underlying data can be elucidated by using different statistical diagnostics
such as monitoring residuals and loadings with respect to the statistical
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confidential limit (Martens and Martens 2001; Smilde et al. 2005). Model
validation includes not only the model’s ability to fit and predict future
data but also an assessment of the calibration data set used for creating
the model. Good calibration data is representative for modeled phenom-
ena and contains no outliers i.e., a differently or badly behaving sample
or variable that would have a crucial effect on the model. Alternatively, if
one uses robust counterparts of ordinary chemometric methods, the out-
liers should not affect the models detrimentally (Daszykowski et al. 2007;
Lin et al. 2007). In addition, choosing the right number of components for
the model is an important aspect of model validation.
In terms of algorithm perspective, model validation needs to be carried
out, since modelling methods are intended to achieve the best fit of data
without any knowledge about its soundness for the real-world (Willigha-
gen et al. 2006). The best-fit approach can easily lead to overfitted models,
i.e. poor models that are not robust and applicable for future data. More-
over, a data set with many variables may lead to chance correlation with
the given response (Willighagen et al. 2006).
Despite the existence of statistical methods, it is best to analyze the func-
tionality of the model, if possible, by using an external test set which is
independent of the calibration data (Smilde et al. 2005; Willighagen et al.
2006; Dahl and Esbensen 2007; Golbraikh and Tropsha 2002; Vandeginste
et al. 1998). In addition, the visual appearance of loadings (Andersen and
Bro 2003), common sense and understanding of the applied analysis, ana-
lytical and measuring methods need to be taken into consideration in the
evaluation of model performance (Smilde et al. 2005; Doherty and Lange
2006). Badly validatedmodels may lead over-fitted, non-robust models and
ultimately to false conclusions.
In the following sections, some of the most commonly utilized valida-
tion methods are presented.
2.6.1 T2 diagnostics
T2 diagnostics is used to define statistical confidence limits for multivariate
model (Hotelling’s T2). It is computed as follows
T2i =
F
∑
f=1
t2i f
s2t f
(2.27)
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The T2 value is a measure of the sample distance from the mean of the
multidimensional model plane, F is the number of latent variables and s2t is
the estimated variance of the score vector ti. For new data, it is an indica-
tion of whether or not the new data is fitting into the model plane (Kourti
2006). It is used in multivariate process control charts in order to assess if
the process is under control or it can be used for outlier diagnostics.
2.6.2 Residual (Q) diagnostics
Residual diagnostics is used to assess the relevant number of components of
the model, the goodness of the calibration set, outliers and fault detection in
process chemometrics (Smilde et al. 2005; Bro 1998; Wold et al. 1998; Miller
1995; Kourti et al. 1995; Qin 2003; Chiang and Colegrove 2007). Residual
refers to the part of the data that is not modelled and assumed to consist of
noise or redundant random information and it is computed as
EX = X− Xhat (2.28)
EY = Y− XB (2.29)
where EX(IxJ) and EY(IxJ) stand for residual matrices, X and Y original data
matrices, respectively, Xhat for modelled data matrix and B denotes regres-
sion coefficients matrix.
In calibration, the appropriate number of components is usually ex-
tracted when residuals contain only unsystematic variation (Smilde et al.
2005). Especially in the case of spectral data, the systematic variation
in residuals may indicate that some spectral information is unmodelled
(Smilde et al. 2005). However, the unfilled assumption of the model struc-
ture can be reflected in the residuals and thus bias the residual analysis
(Smilde et al. 2005). Nonetheless, it should be noted that the calibration set
and the final model define the common object.
In the case of outlier diagnostics, the normal sample has small residuals
in contrast to the outlying object (Daszykowski et al. 2007). If the predicted
data set encompasses similar residuals of the magnitude the test set is con-
sistent with the calibration data and the prediction can be expected to be
valid (Bro 2003). If, instead, the magnitude of residuals of the test set is
obviously greater than those in the calibration data, the existing model is
not able to estimate reliably the new source of variation which have been
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introduced (Bro 2003). This might be the case for instance with process
monitoring when the process is about to move to an unwanted direction or
some new interferent has been introduced into the system.
2.6.3 Cross-validation (internal validation)
Full (leave-one-out, LOO) and leave a portion out cross-validation (CV)
methods are two widely applied methods for assessing the number of
model components i.e. underlying latent structure in the data with an in-
ternal test set (Bro et al. 2008; Golbraikh and Tropsha 2002; Vandeginste
et al. 1998). The rationale behind the applicaton of CV is to avoid overfit-
ted models to be determined (Bro et al. 2008; Höskuldsson 1996).In some
cases, CV is used for judging the goodness of the model, i.e., validating the
model predictivity when the external data set is not available. However, it
has been demonstrated that cross-validated variance explained Q2CV does
not provide reliable estimate for predictive power of the model (Golbraikh
and Tropsha 2002). Thus, it should be used only for assessing the number
of the model components and as a starting point in the model evaluation.
The basic principle of cross-validation is to build a model and leave one
or several samples out from the modelling at a time and then to test the
model performance by predicting the latent values or response with the
existing model (Brereton 2003; Vandeginste et al. 1998)
PRESS =∑ (yi − yi,hat)2 , (2.30)
RMSECV =
√
PRESS
I
(2.31)
where PRESS stands for prediction error of sum of squares, RMSECV for
root mean square error of cross-validation and yi is the reference value and
yi,hat predicted value of response, respectively and n number of samples.
For example, in the case of PCA, yi is replaced by X in Eq. 2.30 and yi,hat by
Xhat.
Themodelling cycles continues until all data rows are used both inmod-
elling and internal testing. Summing over the prediction error for the test
set for every component leads to determining the number of components
that best describes the data using Eq. 2.30 and Eq. 2.31. This involves plot-
ting RMSECV as a function of the number of components, where RMSEP
(root mean square error of prediction) typically diminishes until reaching
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the maximum number of components that are less likely to explain the
noise (Brereton 2003).
There has been some criticism about the cross-validation suitability and
limitations of using CV for variety of data in PCA analysis and CV algo-
rithms from different chemometric software package (Bro et al. 2008). By
using an internal validation of the model, the predictive performance for
future samples from different laboratory, locations, batches or process time
is still unknown (Brereton 2003). Bro et al. (2008) showed that some of the
CV algorithms applied for PCA in different programs can bias the original
purpose of CV, i.e., the model has to be independent from the part of the
data being left-out and tested. It has also been debated whether or not the
LOO- method will provide overfitted models (Kalivas 2005; Vandeginste
et al. 1998) and that CV is only valid for comparative purposes of regres-
sion models built from the same calibration set (Dahl and Esbensen 2007).
2.6.4 Split-half analysis
Split-half analysis is intended for assessing the performance of the models
that are unique and do not have rotational freedom, e.g., PARAFAC and
factor analysis (Harshman1984) (Smilde et al. 2005). The name of the anal-
ysis is a direct reference to the concept of the method, i.e. the original data
matrix has been divided into two data blocks that are modelled indepen-
dently. Due to the uniqueness of these kinds of models, the model loadings
will be similar for subsets if the correct number of components has been
extracted (Smilde et al. 2005). It should be noted that splitting needs to be
performed in a mode where as a result, subsets exhibit the region of interest
and most likely are to be decomposed with the same latent factors. How-
ever, if the number of samples in the splitted mode is too few, the replicate
latent variable decomposition may not be feasible (Smilde et al. 2005).
2.6.5 Core consistency
The core consistency diagnostic (CORCONDIA) indicates the goodness of
fit of decomposition multi-way models (Bro and Kiers 2003). CORCON-
DIA compares the truly trilinear structure to the model estimated core
which varies on a scale from 0 to 100%. If the value of core consistency
is near zero, the model has too many or too few components. If it is near to
100%, then the fit of the model is perfectly trilinear.
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2.6.6 R2/Q2/r2 criteria
Since chemometric models turn data variation into meaningful informa-
tion, there are some indices which can describe this modelled variation.
The terms R2X and R2Y denote variance explained by the model whereas
Q2X and Q2Y imply variance explained of the external test set or the pre-
dicted data. The term r2 refers to the correlation between reference value
(yre f ) and estimated value (yest) in regression analysis. These terms can be
categorized in percents, i.e. between 0 to 100%.
Sometime correlation coefficients between the values estimated and the
reference data points are utilized to estimate the quality of the model. How-
ever, care should be taken when working with r2, since wrong conclusions
can be made without inspection of a graphical plot or the range of the data
points. Fig. 2.6.6 shows an example of a situation where the correlation co-
efficient indicates that the estimated data points correlates well with refer-
ence points (left-hand side) whereas in the other example (right-hand side)
false conclusions would be made if simply based on the correlation coeffi-
cient.
2.6.7 RMSEP
Root mean square error of prediction (RMSEP) is a measure of prediction
uncertainty for the independent test set. It is defined as follows:
RMSEP =
√
PRESS
I
(2.32)
where PRESS stands for prediction error of sum of squares (Eq. 2.30) and
yi is the reference value and yi,hat predicted value of response, respectively
and I number of samples.
RMSEP can be used as a criterion to determine the model complexity
in cross validation, as noted earlier, and can be used for comparisons be-
tween several models constructed with different data sets. When assessing
the goodness of the model, RMSEP should be compared to the measure-
ment error of the reference analysis method as a way of assessing model
performance (Bro 2009; Westerhuis et al. 1997).
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Figure 2.5: Example of different correlation coefficients.
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2.6.8 Leverage and influence diagnostics
Leverage diagnostic, i.e., the measure of sample or variable influence on the
model has been used for assessing the model fit for calibration data and for
outlier detection (Smilde et al. 2005; Vandeginste et al. 1998; Miller 1995). A
sample with a low leverage value has a low impact in the model whereas a
sample with high leverage may cause fatal damage to the calibration model
if it contains erroneous information. In general, the low leverage value indi-
cates that the sample is an average sample that contributes to the model. In
contrast, the high leverage sample contains some specific variation which
needs to be checked carefully. Thus the high leverage value of certain sam-
ple may be an indication of an outlier that is a differently behaving sample
(Smilde et al. 2005; Vandeginste et al. 1998) or it may be the source of infor-
mation that is important for the model but which at the present is unrep-
resented (Smilde et al. 2005). According to Martens and Martens (2001), a
sample having a leverage value twice as large as the others in the calibra-
tion set may be considered as an outlier. However, its relevance and the
distribution of calibration set needs to be checked. If there is a single sam-
ple with high leverage value, it can be questioned, if the calibration set is
probabilistic and covers the variance or modelled phenomenon adequately.
Leverages of samples can be observed in X (Eq. 2.33) space or modelling
of y (Eq. 2.34) (Höskuldsson 1996; Martens and Martens 2001).
hi,X = ti
(
TTT
)−1
tTi +
1
I
(2.33)
where hi,X is the leverage and ti the score vector of respective observa-
tion in X(IxJ) space, and 1I is the offset term for mean centered data with I
observations (Smilde et al. 2005). In the case of multi-way models, loading
matrices are subsituted into Eq. 2.33.
hi,Xyi = hi,X +
(yi − yi,hat)2
(y− yhat)T (y− yhat)
(2.34)
where subscript hat denotes the estimated y value.
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3 PROCESS ANALYTICAL TECHNOLOGY,
PAT
PAT stands for Process Analytical Technology and it aims to change the
present thinking and operation within the pharmaceutical industry to-
wards real-time process control or monitoring instead of the intermediate
or end product testing off-line (Munson et al. 2006; Scott 2002). FDAdefines
PAT as "a system for designing, analyzing, and controlling manufacturing
through timely measurements (i.e., during processing) of critical quality
and performance attributes of raw and in-process materials and processes
with the goal of ensuring final product quality" (U.S. Food and Drug Ad-
ministration 2004). The PAT approach applied to the pharmaceutical pro-
duction is intended to enhance process understanding, hasten analysis of
intermediate and final product and provide better control of the process
(Scott 2002).
PAT is a synonym for PAC (process analytical chemistry) (Workman
et al. 2007) since it uses similar methods, e.g. multivariate and spectroscopic
techniques, that convert variances in the process into information (Balboni
2003). These methods are well known and have been applied in process
chemistry and process lines in other industries for several decades (Hardy
and Cook 2003; Kourti 2006). According to FDA, the PAT guidance lists
the core concepts of PAT and process understanding to be (1) multivariate
data acquisition and analysis tools, (2) process analyzers and sensors, (3)
process and endpoint monitoring and control, and (4) tools for information
management for ongoing improvement. Thus, chemometrics plays a criti-
cal role in the PAT context and this needs to be appreciated (Balboni 2003;
Miller 2005).
PAT, as well as PAC, tools refer to measuring and analyzing methods
that provide real-time information about the process state and control, and
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improve understanding of the process. PAT involves multivariate concep-
tual and chemometric methods to be applied for the processes and pro-
cess lines since processes, such as pharmaceutical processes are typically
multivariate in their nature (Kourti 2006; Munson et al. 2006; Scott 2002).
Chemometric methods can extract relevant information from the process
variations such as conditions for normal operating of the process and these
can be used to build real-time multivariate control systems. With the help
of chemometrics, the models between properties of raw materials, interme-
diate products and end product quality can be constructed. In addition,
critical process parameters can be detected and controlled, leading to more
consistent production with fewer batch failures (Morris et al. 1998; Scott
2002; Wold et al. 2006). The risk analysis of the process is one important
aspect of PAT manufacturing. The purpose of the risk analysis as well as
PAT is to minimize and prevent serious risks such as a pharmaceutical for-
mulation consisting of the wrong amounts of constituents, wrong particle
size distributions or data from the process being acquired and/or analyzed
insufficiently (Wold et al. 2006).
One of the central goal of PAT is the process understanding, for ex-
ample real time release (RTR) testing, sometimes called parametric release
(Morris et al. 1998), i.e. the product is ready for marketing after the final
processing step, without needing to undergo time-consuming quality tests,
since the quality has been controlled during manufacturing. The basis for
RTR is Quality by Design (QbD), which is a key concept in PAT (Yu 2008).
This means that quality is built into the process, and end product quality
is predicted reliably and correlated with intermediate products and real-
time process data (Balboni 2003). The critical quality attributes (CQA) af-
fecting the performance and quality of formulation, such as particle size
and distribution or drug content in a lot, are defined and detected through-
out the process and sub-processes (Morris et al. 1998). The off-line quality
tests for drug products and also intermediate products of the process may
not be totally replaced by PAT operating real-time quality control, but in-
stead, PATwill definitely speed up the release time and end product testing
maybe reduced to a confirmation test. Furthermore, RTR will provide more
uniform product quality and minimize sampling errors since testing being
conducted in-line (Morris et al. 1998).
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In the PAT concept, the following terms are used to describe analyzing
event; in-line, on-line, at-line and off-line. In-line means that the measure-
ments have been acquired from the process stream, on-line is similar but
the sample has either been removed and returned to the process in order
to conduct measurements or measurements are run periodically. At-line
means that the sample is removed for running the measurements in the
vicinity of the process stream but it is not returned whereas off-line means
that the sample has been transported to some other laboratory for analysis.
Two cornerstones of PAT ideology are as follows: (1) non-destructive
measuring methods that gather real-time process data, which will be de-
scribed shortly in the next chapter and (2) multivariate methods in chemo-
metrics that analyze and transform (convert) data variation intomeaningful
information, which were described in Chapter 2.
3.1 Non-destructive methods in PAT
Non-destrucitve methods are essential measuring tools to achieve process
related information since they do not destroy a sample and can be applied
without any contact with the sample. One of the basic non-destructive tools
for process monitoring is a thermometer. However, spectroscopic meth-
ods, in particular NIRS (Near infrared spectroscopy), will often considered
more advantageous in the context of PAT (Blanco and Alcala 2005; Cogdill
et al. 2005). These methods can be considered as detection tools for spe-
cific multivariate fingerprints of the components (Berntsson et al. 2002)
or the process. Spectroscopic methods can be divided into whether they
are based on electromagnetism or an sound waves. Their common prin-
ciple is an energy spectrum that they produced. The spectrum is a range
of adjacent wavelengths or frequency points that include the characteristic
sensitivity or absorbancy of electromagnetic or sound wave (pressure) for
a specific material. The basic concept of the spectrum is that each spectrum
includes specific information, this can be about one molecule or one atom
or infinitely many. The sensitivity of the gathered spectrum depends on the
wavelength in which the target material is either illuminated or passively
detected. Different wavelength ranges have different energetic properties.
For instance, the NIR electromagnetic radiation that is considered is in the
range 780-2526 nm (Reich 2005) causes vibration and stretching of bonds.
On the other hand, much smaller wavelengths, X-ray in a range of 10 to 0.01
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nm, can penetrate deeper into the material and interact between atoms by
causing absorption or emissions of photons to the incident radiation source.
The interest in utilizing different spectroscopic methods is due to
their ability to acquire and carry physicochemical information, in a non-
destructive manner. As mentioned, NIR is the most commonly used tech-
nique to characterize tableting unit operations (Reich 2005; Luypaert et al.
2007; Roggo et al. 2007) since the NIR spectra of solid material contains a
plethora of physical and chemical information and process-related changes
(Roggo et al. 2005). Recently, also Raman and terahertz spectrocopies have
attracted interest as potential PAT tools for use in pharmaceutical research
(McGoverin et al. 2008). Both NIR and Raman require no sample prepara-
tion hence they are non-destructive PAT tools. The difference between the
analysis of NIR and Raman is that the latter method displays more distinct
spectral peaks (Sasic 2007) whereas NIR produces a broad and overlap-
ping absorbance spectra which needs proper pre-processing prior to anal-
ysis. However because the spectra include multidimensional fingerprint of
chemical constituents and even physical properties, multivariate analysis
tools will be needed in the analysis.
It should be noted that even though optical spectroscopic methdods are
useful PAT tools, the probe contamination and sampling location may rep-
resent a problem. Thus, more research concerning other non-destructive
measuring devices e.g. those based on sound waves (acoustic emission) or
electric properties of the system of interest (electrical capacitance) should
be continuously carried out. Summing up, it is clear that one measuring
tool may not be able to detect all compounds or process fluctuations due to
limited detectability of the analyte of interest or the tendency to destroy or
change the target which is being measured.
3.2 Tablet manufacturing
The tablet is themost widely used orally administered dosage form because
of its many advantages such as easy administration, the cost effectiveness
of its manufacturing and the stability of the formulation (Varma et al. 2004;
McCormick April 2005; York 2002). The tableting process aims to put a drug
substance into a 3-dimensional preparation and to implement it in such a
way that the drug product is safe and functional for the purpose for which
it is intended. Tableting consists of several intermediate phases, called unit
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-wei -mix1 -gra -dry sie - mix2 - tab - pack
Figure 3.1: The examples of unit operations in tableting. Wei refers to
weighting of mixture components, mix1,2 to the first and second mixing,
respectively, gra referes to granulation, S to sieving, dry to drying phase, sie
to sieving, tab to tablet compression and pack to packaging.
operations (Skibsted et al. 2007; Doherty and Kettler 2005). The unit oper-
ations ranges from raw material characterization to tableting, tablet testing
and packaging (Fig. 3.1). Tablet production by direct compression is the
most desirable option for pharmaceutical companies, in particular for the
generic manufacturer, since it does not need the powder granulation and it
is more cost effective (McCormick April 2005).
Different unit operations exhibit multivariate characteristics since each
of their (intermediate) products depends on the loads of different variables
and measurement conditions. Variation in the raw materials e.g. due to
particle size distribution or different manufacturer can affect the output of
unit operations. Despite this multivariate nature, the processes still tend to
be monitored univariately. Some of the unit operations, such as blending
and granulation have been equated to "art instead of science" (Muzzio et al.
1997; Tsujimoto et al. 2000; Iveson et al. 2001; Litster 2003). For instance, the
granulation process is one of the most poorly understood unit operation
so far (Cameron et al. 2005), the success of which depends of many inter-
related process variables. Hence, the reasons for the poor understanding
of processes are mainly due to lack of multivariate process control and de-
tection as well as the lack of real-time information about of process condi-
tions. Even though the FDA’s PAT guidance recommends and encourages
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the Quality by Design (QbD) approach for pharmaceutical manufacturing
in which product quality is assessed real-time, it does appear that the qual-
ity and success of different unit operations relies heavily on evaluating the
output material of sub-processes, off-line (Reich 2005).
3.2.1 Typical tableting control scheme
At present, tableting quality control is carried out by testing (1) raw mate-
rials, (2) in-process materials and intermediate product, and (3) end prod-
uct off-line according to the regulations in the relevant pharmacopeias, and
manufacturing (Munson et al. 2006) is conducted as a fixed process (Yu
2008). A fixed process means that the manufacture is carried out according
to very strict specifications which over time have been discovered to ensure,
at least most probably, a good quality tablet. If some out-of-specification
event occurs during processing, the process is judged to have failed and
all of the materials will be discarded (Yu 2008) without the possibility for
trouble-shooting (Wu et al. 2007). Moreover, univariate control charts are
utilized and different process parameters are recorded individually. The
univariate control charts may or may not detect faults or the success in
the process line i.e. they may well be inappropriate controlling tool for
process and assessing the goodness of the final quality (Kourti 2006; Chi-
ang and Colegrove 2007). The conventional process parameters utilized for
control are time (Westerhuis et al. 1997; Jørgensen et al. 2004; Tabasi et al.
2008), temperature, or other trivial or fundamental measurements from the
process line (Doherty and Kettler 2005) that do not necessarily equate to
appropriate process information nor directly link to quality attributes. In
essence, this means that the process is not understood and optimized in a
manner that a controlling system would either prevent the failures or en-
able the manufacturer to react to process conditions variation by changing
key parameters and thus to stabilize the process. This is fundamentally due
to the unknown causality between processing variables and product qual-
ity (Lionberger et al. 2008). Therefore, batch-to-batch variation exists, but
variation within process conditions are forbidden and neither understood
nor controlled. Thus, it should be noted, that under strict and inflexible
processing conditions, a batch that may possess acceptable properties may
be discarded (Yu 2008).
Since the pharmaceutical industry operates in a highly regulated envi-
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ronment for obvious reasons, each unit operation in tablet production needs
to be carefully tested to guarantee that the product meets the set specifica-
tions. At present, this means much time-consuming off-line testing (Reich
2005) in laboratories with the result being either batch approval or rejection.
At this stage, almost nothing can be done to compensate for the process and
prevent rejection. Thus, by utilizing the more advanced techniques applied
already in other industries including spectroscopic tools, chemometrics and
multivariate control charts (Kourti 2006) for tableting process control from
the beginning to the end, a more in-depth knowledge of the process and its
variable correlation structure (Chiang and Colegrove 2007) is gained and
eventually, process quality risks are minimized (Bakeev 2005).
3.2.2 Quality control scheme by PAT approach
In principle, there are three different approaches to apply PAT in tablet
manufacturing. The most conventional is to concentrate on modelling one
unit operation at time. Next level PAT applications include connecting two
or several unit operations, e.g. via regression models, which is useful since
anything that has happened in process conditions in the preceding phases
will affect the subsequent process phases (Skibsted 2005; Kourti 2006; Skib-
sted et al. 2007). For instance, an optimal implementation of PAT in tablet
manufacturing requires the unit operations such as wet granulation and
end product quality to be linked with multivariate latent variable models
(Westerhuis et al. 1997; Skibsted et al. 2007). The third and most desired
PAT implementation level is to connect all critical unit operations together
and create a feed-forward controlling system. The feed-forward control
system enables process conditions to vary but still to be compensated to
reach the desired output. Lastly, if all the unit operations are controlled
continuously with respect to critical process parameter and critical qual-
ity attributes (CPP and CQA, respectively) real-time-release of end prod-
uct is possible (Yu 2008; Rathore et al. 2009). This leads to the result that
only those batches that deviate from a pre-determined process signature are
tested off-line or rejected (Rathore et al. 2009). However, only a very few
application connecting several unit operations with latent variable models
have been published.
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3.2.3 Examples of process control strategies
According to PAT, and more generally in process optimization, critical pro-
cess parameters (CPP) that affect critical quality attributes (CQA) need to
be defined and controlled and their interrelationships understood. The im-
portance of a control strategy for the manufacturing is emphasized (Lion-
berger et al. 2008; Yu 2008; Kourti 2009), but nonetheless, only a very few
case studies have been published concerning pharmaceuticals (Westerhuis
et al. 1997; Skibsted et al. 2007).
In 1997, Westerhuis et al. (1997) considered a tablet manufacturing with
a granulation step as a two-step process where first the powder blend was
granulated and subsequently tabletted. This study is a unique example
of optimizing and predicting the multi-step process of tableting and how
the different unit operations can be treated as a whole. This study will be
scrutinized thoroughly later, in Chapter 5.3.4.
After a 10 year gap, Skibsted (Skibsted 2005) depicted in his thesis an
example of a feed-forward control and real-time release system for interme-
diate and end product for tablet production. Skibsted et al. (2007) utilized
a feed-forward PLS regression model which was constructed using the pre-
ceding conditions of unit operation for assessment of conditions of the next
unit operation, i.e. settings of a granulation parameter in order to obtain
the desired tablet quality. Also, Kourti (2009) illustrated conceptually some
years later, in 2009, the main principles of feed-forward control as it ap-
plies to tablet production by emphasizing the importance of the actions to
be made for N+1 unit operation according to the latent projection model of
N unit operation outcome. In this way, raw material variation and batch-
to-batch variation could be compensated by affecting process conditions in
order to achieve the target product.
A very recently framework published by Huang et al. (2009) outlined
also how multivariate data analysis could be integrated into tablet produc-
tion from the beginning to the final product evalution. In Fig. 3.2, box-like
chart shows the principal idea of managing the tableting process, which
in fact can be applied on other batch processes within pharmaceutics. The
process under study constructed of high shear wet granulation, milling,
blending, compression and coating unit operations. Milling and coating
are not a part of this thesis, and thus will not be further discussed. How-
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Figure 3.2: QbD approach to tableting process. QTPP is referred to as the
quality target product profile, CQA stands for critical quality attribute and
CPP to critical process parameter.
ever, in this study PCA and PLS analysis was applied only for exploratory
purposes without any final predictive model and process control.
In contrast to previous examples, the most conventional way of apply-
ing PAT for tablet production is optimizing a distinct unit operation to yield
a desired output (Kourti 2009).
3.2.4 Process signature
The process signature forms the basis for process monitoring and real-time
quality control and it aims to perform a trace of how the process is behav-
ing under normal operating conditions (NOC), e.g., for each N unit opera-
tions separately. The process signature can be considered as a univariate or
multivariate fingerprint of experiments during the course of the processing
time (Fig. 3.3).
It should be noted that CPP that impact on CQA may not necessarily
be one distinct process variable, instead it can be a principal component
or latent variable that comprises the most important effect of variation on
the quality. In this case, the latent variable(s) is considered as a process
signature surrounded by critical control and warning limits. The process
signature is constructed from historical data of the process of well-behaving
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Figure 3.3: The process signature for an arbitrary process. A well behaving
process runs within the control limits as a function of time. Data from the
process is analyzed by PCA and the first latent variable (t1) captures the
most important process information.
batches or processes (Kourti 2006; Skibsted et al. 2007).
3.2.5 Summary of PAT advantages
The advantage of the controlled and well optimized processes, where the
final or intermediate product quality can be predicted using chemometric
models provides batch-to-batch consistency and less batch rejections. Since
intermediate process outcomes can be predicted beforehand and one can
see if the process is about to reach the critical warning limit, the process
personnel may save the batch by altering the settings of the process condi-
tions.
In the following sections, the cross-section of some chemometric appli-
cations providing increased process or product understanding, i.e. PAT
studies within uncoated tablet unit operations and techniques with which
these methods can be applied.
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4 PAT APPLICATIONS ON TABLETING UNIT
OPERATIONS
In this chapter, typical process phases with common problems in tablet pro-
cessing are introduced. Furthermore, the appropriate chemometric and
PAT tools involved are presented. The multivariate control strategy (i.e.
models across several unit operations) is introduced whenever possible.
There are some other unit operations such as solid state screening and dry-
ing phase after granulation that are not considered within the context of
this thesis. Even though the pre-formulation stage introduced at first in
this chapter, is normally not considered as a separate unit operation since
it is a learning phase of formulation design covering the actual unit opera-
tions, it is included here due to its importance in tablet manufacturing. In
the following sections, X in the title depicts the data matrix under consider-
ation.
4.1 Preformulation studies and formulation de-
sign
The foundation for every drug formulation lies in the pre-formulation
phase and how effectively and how well it has been carried out. The pre-
formulation step covers studies which help in selecting the formulation
type, components to include and check their interactions, such as whether
or not to direct compress or granulate the powder blend prior to tableting.
The optimization of tablet manufacturing is also included in formulation
studies such as target dissolution, strength and disintegration time as well
as amounts and types of different fillers and inactive excipients (Hwang
and Kowalski 2005; Gabrielsson et al. 2006; Andersson et al. 2007). Com-
paction profiles such as compaction force and speed and depth of the die are
examined at this phase since all these modify the tablet properties (Haware
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et al. 2009a). The quality target product profile (QTPP), i.e. drug safety and
function sets the limits on the formulation design (Hwang and Kowalski
2005). If the API needs to dissolve rapidly, the formulation has to deliver
this requirement e.g. by adding disintegrants etc. If, on the other hand, the
drug is to be released in a controlled way, e.g. slowly or evenly, the formu-
lation needs to ensure that this happens. Conventionally, the formulation
process has been based on an empirical trial and error approach which is
not the most effective way to conduct this kind of procedure (Leuenberger
and Lanz 2005). Moreover, due to the limited amounts of API, the number
of trials and experiments needs to be minimized (Andersson et al. 2007).
The first step in the manufacture of an oral solid dosage form is to as-
sess the requirements of drug substance to be suited for oral administra-
tion, since the drug substance needs to pass through the gastrointestinal
(GI) tract to its site of action without losing its effectiveness. The drug in-
tended for oral delivery needs to have suitable physicochemical properties
such as appropriate solubility, lipophilicity, permeability and compatibil-
ity with excipients (York 2002; Hwang and Kowalski 2005). To achieve
the appropriate performance, the drug needs to have a certain dissolution
profile and formulation for its intended performance. Biopharmaceutical
classification system (BCS) and Lipinski 5 rule are well known and widely
applied methods for assessing the drug-likeness and orally activeness of a
molecule. However, the concept of orally administered drug is as difficult
as the concept of assessing the characteristic of a drug-like molecule among
the billions of different chemical compounds in the universe. Due to this
unknown field, i.e. unpredictable space of compounds, the properties of
drugs intended for an oral dosage form need to be tested in a case-specific
manner.
The predictive techniques and models have been used in pharmaceuti-
cal pre-formulation studies (Tarvainen et al. 2001; Hardy and Cook 2003;
Korhonen et al. 2005; Suihko et al. 2005; Matero et al. 2008; Pajander et al.
2009) as well as designing of experiments (Hwang and Kowalski 2005; An-
dersson et al. 2007) in order to reduce the time and costs of formulation
development and span the experimental space maximally. Several stud-
ies have utilized computational molecular descriptors to characterize the
physicochemical properties of molecules and pharmaceutical materials for
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predictions or discovering the causality of molecular or material charac-
teristics for further processing (Matero et al. 2008; Allesø et al. 2008; Ko-
rhonen et al. 2005; Suihko et al. 2005; Tarvainen et al. 2001). This research
field comprises quantitative structure-property relationships (QSPR) that
is the correlation between molecular constituents to their physicochemical
properties (Grover et al. 2000a,b). Alternatively, Willighagen et al. have
used the term ’molecular chemometrics’ (Willighagen et al. 2006). Many
properties can be predicted which cover basically all of the preformulation
tests (Wells 2002) ranging frommolecular solubility and lipophilicity (Hu-
uskonen et al. 2000; Cruciani et al. 2000), pKa value (Milletti et al. 2007)
to dissolution (Korhonen et al. 2005; Matero et al. 2008), drug-excipient
compatibility studies (Matero et al. 2008) and tablet strength characteristics
(Andersson et al. 2007). Molecular descriptors are appealing since usually
they can be computed relatively quickly without any experimental work.
Different kinds of neural network and response surface methods (RSM)
have been used in formulation design (Sun et al. 2003; Siepmann and Siep-
mann 2008). In addition, the classical multivariate methods like PCA and
PLS regression have been utilized . The downside of the neural networks
that mimic the visualization ability of human brains are often considered
as black box methods since the data processing is hidden from the user.
Moreover, neural networks are prone to over-fitting (Manallack and Liv-
ingstone 1999) because of inappropriate model validation. On the contrary,
the RSM method, where two or three important variables are changed as a
function of target parameter, lacks the ability to handle a multivariate cor-
relation which is crucial for complex systems such as tablet formulations
(Leuenberger and Lanz 2005).
Next, a few examples of formulation design studies of optimization
where multivariate data analysis has been utilized is introduced.
4.1.1 Multivariate optimization in tablet manufacturing
Gabrielsson et al. (2006) proposed principal properties (i.e. principal com-
ponents) of inactive constituents to evaluate and predict new mixture char-
acteristics based on the mixture design and known additives. According to
these assumptions, newmixtures close to known ones in the score space in-
hibit similar physicochemical properties and can be thus used as alternative
excipients. The Xmatrix consisted of NIR or FT-IR data of mixture blends.
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Andersson et al. (2007) used PLS and simulated simplex methods to an-
alyze and optimize simultaneously tablet strength and dissolution and to
conduct as few experiments as possible. The results indicated that the tar-
get strength and fast dissolution were attained with the amounts of con-
stituents, i.e., a specific filler ratio and a high concentration of disintegrant.
The filler is used in tablets in order to obtain the desired size and disinte-
grant to speed up drug release. In this study, the conclusions of the most
important DoE variables to affect response were drawn using a PLS VIP
plot (Wold et al. 2001).
Recently, Haware et al. (2009a) evaluated PLS and PCA as a "formula-
tion development tool" in the case of placebo tablets. In this study three
differently behaving excipients (i.e. plastic, fragmentation and elastic com-
pression behaviour) were compressed with varying formulation parame-
ters utilizing full-factorial design. The formulation parameters were the
punch velocity of tablet compressor, lubricant and fourth excipient frac-
tions. The compression properties of formulations, were assessed using
loading and weight plots of PCA and PLS, respectively. However, the
study provided only an exploratory aspect instead of a quantitative aspect,
which is of great interest in the pre-formulation stage. In the second study
of Haware et al. (2009b), the quantitative PLS models were developed be-
tween tablet tensile strength (quality attribute, the Y matrix) and tableting
process parameters (punch velocity) andmaterial properties (startingmate-
rial variable size distribution and processing method). In the experiments,
one excipient of different grades served as the basis for the variation in the
manufacturing mode and particle size distribution. The PLS models for
compression behavior, i.e. tensile strength, were designed by leaving one
material (one excipient of different grades) out of each time and to imple-
ment it in an external test set. Although there was good predictive ability
for the models, no consensus was achieved about what is of the most de-
scriptive and useful model as an formulation development tool.
4.2 Mixing
Only a few drug compounds can be tabletted without any excipients
(Twitchell 2002) because of the compaction characteristics and amounts of
constituents. Usually, the excipient forms the tablet structure together with
an active pharmaceutical ingredient (API) (van Veen et al. 2005). The pur-
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pose of the mixing unit operation is to prepare a homogeneous mixture
with a predefined error deviation because the perfect mixture is unattain-
able, particularly when the mass of the lot and the density differences in-
creases. The importance of blend homogeneity or uniformity is to assure
that the same amount of API is compressed into each tablet of the batch
(Skibsted et al. 2006) and therefore it needs to receive special attention in
tablet manufacturing. If the mixing is not carried properly nor analyzed ac-
curately (Muzzio et al. 2003) variation between API content of tablets may
increase (Skibsted 2005) which may lead to batch rejection or the recall of
the product (Muzzio et al. 1997; El-Hagrasy et al. 2001). However, the API
variation within the tablets may also be due to blend segregation during
tablet compression, large size differences between components (Berntsson
et al. 2000; Muzzio et al. 2002), lack of granulation step or even mix transfer
or storing between unit operations (Muzzio et al. 1997, 2002, 2003) and is
not necesseraly due to a badly performed mixing phase.
A classical way to blend a drug substance with excipient(s) is to mix
them in a blender for a pre-defined time. After a pre-determined mixing
time, the homogeneity of the mixture is tested invasively and if it is not
meeting the acceptance level with respect to API content, mixing is contin-
ued for a pre-determined time. The common and acceptable way to control
the homogeneity of a mixture is to take a few samples from the lot using
a sampling probe, then dissolve the mixture in to the buffer and estab-
lish the API content with a UV-spectrometer (ultraviolet spectrometer) or
a high-performance liquid chromatography (HPLC), off-line (Muzzio et al.
1997, 2003). It has been known, already for years, that the analysing tech-
niques are time-demanding and labour intensive (Lai et al. 2001; Skibsted
et al. 2006; Wargo and Drennen 1996), produce limited number of samples
(Muzzio et al. 2003; Skibsted et al. 2006) and do not take into account dif-
ferences between individual processes nor mixture components (Skibsted
et al. 2006) or the distribution of excipients (Reich 2005). Morever, exces-
sive time of mixing can cause segregation between components e.g. due
to particle attrition and thus particle size and shape distribution and this
can worsen the homogeneity (Wargo and Drennen 1996; El-Hagrasy et al.
2001; Lee and Lin 2004; Skibsted et al. 2006; Skibsted 2005). In addition,
the sampling procedure by a thief probe may face significant problems in
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the sampling such as segregation and unrepresentative sample extraction
(Muzzio et al. 1997, 2003; El-Hagrasy et al. 2001; Berntsson et al. 2002) and
analytical errors (Lai et al. 2001) let alone its relevance to future formula-
tions (Paakkunainen et al. 2009). As an alternative to the classical way, a
real-time or at-line measuring tool for detecting mixture homogeneity and
mixing end-point that is in accordance with the PAT regulations and takes
into account representativeness of the samples should be preferable.
4.2.1 NIR as an X in mixing
Both qualitative and quantitative multivariate modelling approaches have
been utilized for monitoring of blending process. NIR instruments are
widely used PAT tools here to measure the success of the mixing process
(Wargo and Drennen 1996; Berntsson et al. 2002; Skibsted et al. 2006). Two
of the earliest implementations using NIR and multivariate data analysis to
qualitatively monitor the pharmaceutical blending process were the studies
of Wargo and Drennen (1996) and Sekulic et al. (1998). Wargo and Drennen
(1996) used a bootstrap technique for PC compressed NIR data to assess
uniformity of the blend and to define the optimal mixing time, off-line. The
models revealed that excessive time of mixing decreased the homogeneity
which was later supported by subsequent researchers (El-Hagrasy et al.
2001; Skibsted et al. 2006). Sekulic et al. (1998) applied a qualitative PCA
and SIMCA model to on-line NIR data acquired from mixing and com-
pared the results with other methods (spectral dissimilarities, mean stan-
dard deviation and pre-processing options) in blend homogeneity determi-
nations.The batches with different target homogeneity compositions were
separated by the PCA model whereas the homogeneity of the batches with
a similar target composition could be evaluated using the SIMCA model
consisting of one class, i.e., a homogeneous blend.
Berntsson et al. (2002) applied NIR and PLS for in-line determination
of powder content of a powder mixture prone to segregation. The cali-
bration model was constructed using the so-called mean-spectrum method
(Berntsson et al. 2000) that enables one to construct a calibration model for
determining the overall API content in binary powder mixtures using rela-
tively few, but representative, randomly acquired, calibration samples. The
first loading of the PLS model corresponded to the difference spectrum of
pure mixture components revealing that PLS was able to capture variation
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within the powder mixture. Rather similarly, Rantanen et al. (2005) utilized
PCA scores constructed from in-line NIR data of mixing corresponding to
three mixing components, API and excipients, for determining the mixing
end-point. The levelling off of the root-mean-square values of three differ-
ent scores during the course of time reflected the increased blend homo-
geneity.
El-Hagrasy et al. (2001) performed preliminary SIMCA analysis for NIR
spectra acquired from six different locations of the blender during mixing.
There were four SIMCA classes; cluster A consisting of spectra at time point
zero, clusters B and C of spectra during premixing and cluster D of spec-
tra at the homogeneous stage. The model provided for the test for homo-
geneity of the sample, on-line. Furthermore, the study indicated that the
end-point for mixing depended on the API concentration and individual
batch emphasizing the major benefits for real-time monitoring system of
mixing (El-Hagrasy et al. 2001). Subsequently El-Hagrasy et al. (2006a,b);
El-Hagrasy and Drennen (2006c) studied systematically the effect of pro-
cess variables on blending and spectral pre-processing on variability in the
data (El-Hagrasy et al. 2006a), developed qualitative SIMCA (El-Hagrasy
et al. 2006b) and quantitative real-time models (El-Hagrasy and Drennen
2006c) for blend homogeneity and end-point evaluation. The first study
showed that 2nd derivative pretreatment applied from the NIR data from
batches with varying process conditions could minimize the batch-to-batch
variability (El-Hagrasy et al. 2006a) thus could benefit the global (robust)
model to be constructed (El-Hagrasy et al. 2006b). The studies (El-Hagrasy
et al. 2006a; El-Hagrasy and Drennen 2006c) highlighted the importance of
deeper knowledge of the blending process, e.g., to be able to place the de-
tector into a representative site or to construct reliable end-point control in
order to perform high quality batches.
Sulub et al. (2009) developed an off-line PLS calibration model to pre-
dict the API concentration on-line in the course of the blending process.
The end-point for blending was achieved when the desired API concentra-
tion was steady as predicted by the model. When this model was utilized
for separate powder mixtures it was possible to avoid the stopping of the
blending process which has been the common approach in earlier applica-
tions (El-Hagrasy et al. 2006a,b; El-Hagrasy and Drennen 2006c). Shi et al.
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(2008) utilized the PLS model with NIR data for in-line detection of blend-
ing end-point and also the batch-to-batch variability of the end-point. In
the comparison with the traditional end-point detection method, the mov-
ing window standard deviation (MVSD), PLS model was more robust on
the basis of variable process conditions.
However, even though NIR is a very useful PAT tool, probe contam-
ination and locations may represent a problem. Thus, more research con-
cerning other non-destructive measurement devices still needs to be carried
out. The fundamental problem with the measuring device is, however, that
the same measurement tool is not relevant for all parameters since either
they do not detect the signal of certain substances at all or they also could
destroy or damage the measurement target.
4.2.2 Raman as an X in mixing
Recently Raman spectroscopy with SIMCA classification was utilized for
in-line and real-time mixing end-point monitoring (De Beer et al. 2008).
The SIMCA model consisted of only one class, i.e. reference spectra ac-
quired from the end of each blending when a homogeneous mixture was
provided. The model was tested with the rest of the data that showed in-
creasing homogeneity of the blend towards the end of the mixing process.
Plotting the peak area of the Raman spectra with the highest variance in a
univariate way was not able to produce the same results.
4.2.3 Image analysis and chemometrics in mixing
Image analysis is an emerging technology for use in analyzing pharmaceu-
tical unit operations since it provides both spatial and spectral data about
the object (Gowen et al. 2008). The image data set is considered as a hy-
percube and most often, conventional chemometric methods such as PCA
and PLS are utilized on unfolded data. Image analysis using multivariate
methods has been recently applied to characterize a small-scale blending
process (Ma and Anderson 2008). The score images performed by PCA
provided qualitative spatial information of the mixture constituents in the
blend whereas the PLS-DA model obtained the concentration profiles of
API at different regions over the course of time. The model estimated that
API variability was highest at the edges of the blender thus suggesting that
a single sensor NIR sampler should be located at the periphery in order to
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detect the sampling end-point.
Advantages of multivariate methods in mixing
The advantage of previously introduced spectroscopic methods together
with multivariate data analysis over the traditional UV method is that in
addition to the API concentration determination they are also able to detect
excipient(s) concentration (Ma and Anderson 2008). This is a clear benefit
since traditionally the API concentration distribution in the mixer has been
considered (Sekulic et al. 1998) and if it is satisfactory the excipient con-
centration is assumed to be satisfactory as well. However, this conclusion
might be misleading as claimed by Ma and Anderson (2008).
However, there are still issues that need to be resolved e.g. sampling,
since for instance, the probe contamination of the NIR device has still not
been solved, although new technologies to prevent the material sticking to
the probe have been published. In addition, issues concerning sampling
need to be taken into account since some PAT methods gather mixing in-
formation from the same single location or from the edge/surface region of
the process stream.
Despitemany applicationswithin powdermixing, issues concerning the
true API distribution within the mixer are still unresolved (Muzzio et al.
1997; Skibsted et al. 2006). The question remains how best to extract repre-
sentative samples for homogeneity evalutions.
4.3 Wet granulation
Granulation is an important unit operation in a pharmaceutical powder ag-
glomeration process in the manufacture of for oral dosage forms within
the pharmaceutical industry. The granulation is carried out to ensure pro-
cessability (Alderborn and Wikberg 1996), i.e. the desirable properties of
the drug-excipient mixture (Bin et al. 1985; Faure et al. 2001; Hemati et al.
2003) to form a homogeneous material (Lee and Lin 2004) with suitable
compaction properties since it prevents segregation of the powder mixture
and powder sticking to the punches of the tablet compressor. Generally
this is the desired way that has been chosen by pharmaceutical companies,
though, for those companies that manufacture generic drug products, the
granulation unit operation is not desirable (McCormick April 2005).
In wet granulation, granules are typically manufactured in two different
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types of wet-agitation equipment, i.e. a high shear mixer or a fluidized bed
granulator (Alderborn and Wikberg 1996; Frake et al. 1997; Faure et al.
2001). In fluidized bed granulation, the wetting and drying phase take
place in the same process equipment (Gao et al. 2002) whereas in high
shear granulation, the wetting phase is carried out in a different appara-
tus from the drying of granular mass. Despite the transfer of granulation
mass into different process phases, high shear granulation is a widely used
method in the pharmaceutical industry because of its efficiency in obtain-
ing dense granules with low porosity (Faure et al. 2001; Gao et al. 2002;
Fung et al. 2006). On the contrary, fluidized bed granulation, due to its
more complicated nature of monitoring and understanding of the process
is a better option when one wishes narrow granule size distribution, i.e. ho-
mogeneous granules (Hemati et al. 2003). However, fluidized bedmethods
are prone to suffer de-fluidization, resulting in undesired oversize granules
called clumps.
Fluidized bed granulation, as well as high shear, is a complex and dy-
namic particle size enlargement process consisting of several overlapping
phases, i.e., mixing, granulation and drying (Faure et al. 2001; Hemati et al.
2003). Granulation consists of three overlapping sub-processes (1) wetting
and nucleation taking place due to a binder solution, (2) granule growth
by collisions, and (3) attrition and breakage upon impact (Iveson et al.
2001). The outcome of the granulation conducted in a fluidized bed de-
pends onmany inter-related processes and product related variables (Fung
et al. 2006), such as inlet air humidity and temperature, spray rate of liquid
binder and binder viscosity, processing conditions and, in particular, the
variability of the size distribution of the starting materials. The variables
are competitive, as well as granulation growth and breakage at some point
(Knight 2004), thus they are difficult to stabilize and their net effects de-
termines the final result (Zhang et al. 2002; Hemati et al. 2003; Thielmann
et al. 2008). In addition, the fact that the granulation process is mainly car-
ried out in a batch mode, leads to the possibility of batch-to-batch variation
(Leuenberger 2001a,b; Vervaet and Remon 2005). Thus, there is increasing
interest towards a continuous type of manufacturing.
Granulation is one of the most poorly understood unit operations due
to the uncontrollable sub-phases during wetting, measurements of process
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Figure 4.1: Example of univariate control. In the left and middle plots vari-
ables x1 and x2 are measured during the course of processing time and con-
trolled separately. The blue lateral lines depict fixed control limits within
the process which is anticipated to be under control. In the plot on the
right-hand side, the variables are plotted with respect to each other. Thus,
by plotting two variables simultaneously, one can see that sample no. 4
(black dot) differs in its correaltion structure from the rest of the samples
(red dots).
parameters that do not provide information, or if they do provide infor-
mation, it tends to be indirect about quality attributes, such as particle size
(Halstensen et al. 2006). Moreover, the conventional manufacturing detec-
tion is univariate detection.
The univariate detection of granulation performance consists of the pro-
cess signature of individual standard process variables that are experimen-
tally known to affect product quality based on the experience of the oper-
ator. For example, time, temperature, impeller speed and pressure mea-
surements are these kinds of variables. It should be noted that today’s best
practice for controlling high-shear granulation in pharmaceutical industry
is the univariate detection of power consumption (Luukkonen et al. 2008),
while the success of fluidized bed granulation is monitored using the tem-
perature difference of in- and outlet or mass temperature (Rantanen et al.
2001). However, the separate detection of variables misses the correlation
structure present in the whole process data which is known to be very crit-
ical to be captured by the process modelling (Kourti 2006) (Fig. 4.1). Thus,
multivariate process monitoring could well be incorporated in granulation,
but until recently, it has not been widely employed.
Next, typical quality attributes, interests and barriers that are confronted
are reviewed, especially in areas where chemometrics has been utilized.
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4.3.1 Granules characterization; size, distribution and
moisture content
The main characteristics to be followed during granulation are the gran-
ule size and granule size distribution since they have a major impact on
tableting, tablet properties and thus on dissolution (Fung et al. 2006). For
instance, if there is a too wide particle size distribution, this may promote
segregation and thus heterogeneous tablets, since smaller granules are an-
ticipated to contain a smaller amount of active ingredient with relation to
bigger granules (van den Dries and Vromans 2002). Usually, the desired
granule properties are attained by following a few process parameters sep-
arately or processing time and finally the end product is tested and evalu-
ated. The moisture content of granules is determined mainly by Karl Fis-
cher titration (KF) or weight loss on drying (LOD) whereas size analysis is
carried out by sieving or laser diffractometry. Occasionally, a batch may
fail but reasons for this often remains obscure. Thus this univariate process
evaluation is not the best option since it lacks both process control and un-
derstanding. If one could achieve proper process control, the batch failures
could be detected earlier and also corrective actions can be initiated. Next,
some examples of multivariate applications will be reviewed to provide
deeper insight into the granulation process.
4.3.2 NIR as an X in granulation
High-shear granulation
NIR spectroscopy together with multivariate data analysis have been ap-
plied to some extent to monitor wet granulation performance and outcome.
The main reason to justify the use of NIR in wet granulation is its sensitiv-
ity towards the water environment (Rantanen et al. 2001) and its ability to
detect physical characteristics such as particle size (Rantanen et al. 2005).
Self-organizing maps (SOM) have been employed for visualization of the
phases of high shear wet granulation processes exploiting both process pa-
rameters andNIR data and assess variables input of phases (Rantanen et al.
2001; Jørgensen et al. 2004). Rantanen et al. (2005) utilized in-line monitor-
ing by PLS for end-point determination by means of particle size. Since
granule size during wet mass processing is greatly affected by water which
is incorporated into NIR signal as well as particle size, orthogonal signal
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correction (OSC) (Wold et al. 1998) prior to PLS was applied in order to
remove the variation due to the presence of water. The end-point of gran-
ulation predicted using OSC-PLS method was comparable to the off-line
measurement of the final granule size.
Fluidized bed granulation
In-line measurements of granule moisture content have been conducted
in a of fluidized bed system by Rantanen et al. (2001). The acquired NIR
data were subjected to PLS and back-propagation neural network analysis.
The variable x vector for sampling points during twelve granulated batch
runs consisted of two NIR water absorbing wavelengths and sixteen pro-
cess variables (e.g. temperature, humidity) with three of them indicating
mixing, wetting and drying phases of granulation. The reference moisture
content of samples was determined using an infrared dryer and sampled
by a thief probe. Liquid addition was seen as a baseline increment in the
raw NIR spectra. Although the neural network did provide better regres-
sion ability than PLS, with the latter technique the correlation between x
variables in different phases could be inspected.
Multivariate statistical process control
Skibsted et al. (2007) successfully developed an early warning system with
multivariate statistical process control (MSPC) charts using PCA and D and
SPE (standard error of prediction) statistics. This process is illustrated in
Fig. 4.2. Two models were constructed; the first model with NIR1 data ac-
quired after the initial mixing of raw materials and the second model with
NIR2 obtained in the postgranulation step. Calibration data consisted of
batches run in normal operating conditions (NOC) whereas test batches
had quality defects, except for one NOC batch. From these two models,
only the second one could separate bad batches with too much fines or
too many coarse particles, from the good batches. The work demonstrates
how the MSPC model benefits the user by omitting the traditional time-
and resource-consuming particle size analysis relying on laser diffractom-
etry (Skibsted 2005) conducted on only two unit operation steps later by
assessing earlier batch quality of the intermediate material.
Even though NIR suffers from probe or window contamination when
utilized as an in-line tool, the building of a special probe port and probe
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Figure 4.2: The unit operations with NIR measurements (NIR1,...,5), in
which NIR3 is acquired on-line while the other measurement were done
later. Wei refers to weighing of mixture components, mix1,2 to the first and
second mixing, respectively, gra referes to granulation, S to sieving, dry to
drying phase and tab to tableting.
system (PATandbeyond), cuvette or off-line analysis may solve this prob-
lem.
4.3.3 Image analysis in granulation
A few applications have been described of image analysis for in-line and
off-line granule size and distribution analysis (Watano andMiyanami 1995;
Watano 2001; Laitinen et al. 2002, 2004). There is, though, only the studies
of Laitinen et al. (2002, 2004) where multivariate data analysis has been ex-
ploited. SOM was utilized for the visualization of granule size distribution
processed by a fluidized bed using off-line image data, which included five
different shape and size parameters (Laitinen et al. 2004). In the first of
these studies (Laitinen et al. 2002) a PLS model was created between par-
ticle size distribution data measured by sieving (Y) and grey scale images
(X) from off-line samples. Images were assembled by illuminating sam-
ples from two opposite directions and calculating the difference matrix on a
pixel-by-pixel basis and subsequently the pixel value distribution was plot-
ted and found to correspond to the particle size distribution as determined
by sieving. The image analysis took 3 minutes whereas sieving required
120 min, highlighting the time-saving benefits of the PLS model.
It should be noted that the image analysis during granulation suffers
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from window contamination if the wet powder sticks to the window and
this can interfere with real-time measurements.
4.3.4 Acoustic emission
Acoustic emission (AE) is an elastic sound wave formed during granula-
tion due to particle impact on granulator wall and other particles. Acoustic
sound waves are not detectable by the human ear, but are detected by a
by piezoelectric transducer. There are two kinds of acoustic emission mea-
suring modes; active and passive (Whitaker et al. 2000). In active acoustic
emission, the acoustic wave is transmitted into a sample system whereas in
passive acoustics, acoustic signals produced intrinsically by the process are
detected. Above the frequency range of 100 kHz, the AE signal attenuates
rapidly in the air but propagates in solid material (Tsujimoto et al. 2000)
thus it is feasible to place a detector on the wall outside of the granulator
and gather signals from the process. Thus, acoustic emission is a totally
non-invasive method, and does not require any windows or orifices since
the piezoelectric sensor can be attached to the outer surface of the granula-
tor chamber. AE appears to be very feasible for measuring particle proper-
ties as well as granulation process if supplemented with multivariate data
analysis (Halstensen et al. 2006).
The first implementation utilizing multivariate data analysis for acous-
tic emission data from pharmaceutical granulation was carried out by
Whitaker et al. (2000), where PLS was used to predict granule size. Mea-
surements from the end of the process were used in the calibration. An
adequate correlation between AE and granule median size was revealed.
However, there were some problems of reliability of reference particle sizes
versus prevailing acoustic emission signal, though this may have been due
to since sieving of granules during the post-process analysis which may
have affected the granule size.
Recently, an acoustic emission method has been exploited to character-
ize the mean granule size in a high-shear wet granulator (Papp et al. 2008)
with a granulation end-point (Hansuld et al. 2009). Hansuld et al. (2009)
utilized the PLS-DA method only to select the frequency regions that cor-
responded to manually determined wetting, end-point and over-wetting
zones. These regions were subsequently transformed into a power spec-
trum and used for univariate detection of end-point. On the contrary, Papp
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et al. (2008) subjected AE data from different batches to PCA and PLS anal-
yses. Granule end product moisture content and particle median size and
size distribution were predicted. However, the interpretation of AE signals
even if combined with multivariate data analysis, can be very complicated.
4.3.5 End-point detection
The main goal to monitor granulation is to define the process end-point
since overwet granules, too wide size distribution, and too fragile or fine
granules are undesired. The granulation end-point has been assessed con-
ventionally by using either a fixed time (Jørgensen et al. 2004) or the
amount of granulation liquid, that is required to achieve the desired out-
put. The drying end-point may also be controlled using a thermometer
or measured at a fixed time. However, if one uses a fixed time one does
not obtain thorough process control or any understanding of the process,
i.e. real-time control would be an advantage. Examples of some feasi-
ble tools have been reviewed in this chapter. However, Leuenberger et al.
(2009) very recently questioned the end-point seeking by emphasizing that
no global end-point exists and end-point of granulation is formulation de-
pendent and case-specific.
4.4 Tablet compression
Tablets are compressed from the powder mixture (or granules, alterna-
tively) using either a single-punch or rotary compression (Alderborn 2002).
Compression consist of different phases, i.e. die filling by the powder, tablet
formation and tablet ejection, i.e. removal of the tablet from the die. In
tableting, attractions due to interparticle bonding, such as hydrogen bonds
are formed and depending on the material properties, fragmentation, elas-
tic or plastic deformation may take place. Most typically there are addi-
tives in the formulation e.g. excipient(s), lubricant, disintegrant, binder and
filler. The excipients greatly affect tablet matrix formation by maintaining
its intact shape whereas disintegrants promote drug release after adminis-
tration. The function of a lubricant (magnesium stearate is mainly used) is
to prevent the tablet from sticking to the punches after compression and to
improve the flowability of the blend (Zuurman et al. 1999). The filler is
used to increase tablet mass and thus volume.
Typical problems that affect tablet quality are weight variation between
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tablets e.g. due to poor flowability of powders (Huang et al. 2009) and
uneven filling of dies (Paakkunainen et al. 2009), and the tablet sticking to
the die wall in the ejection phase which can affect the texture and compo-
sition. During die filling, segregation between larger and smaller particles
may occur causing uneven distribution of mixture component in the tablet.
In general and according to the above literature survey the very few of
these processes in tablet compression phase cannot be handled by chemo-
metrics. However, compression profile and tableting is usually based on
pre-formulation stage trials or more sophisticated and planned experi-
ments. Nonetheless, the output of the tablet compression unit operation,
i.e. tablets, can be characterized with the aid of chemometrics as will be
describes in the next chapter.
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5 PAT APPLICATIONS ON UNCOATED
TABLET QUALITY TESTING
The prepared tablet must be functional, safe for administration, contain pre-
defined amounts of ingredients and has to remain intact in every process
phase of its lifetime; during packing, storage and transport. The common
ways to test the (uncoated) tablet quality according to pharmacopoeia are,
time demanding and destructive i.e. dissolution tests, mechanical testing,
API content determination, and dimension and weight testing. With the
present methods, only 30 out of 4 000 000 tablets, i.e. less than 0.00075%
are analyzed (Cournoyer et al. 2008). The desirable tests need to be rapid
and accurate (Damiani et al. 2005), repeatable and robust and thus alterna-
tive methods would be welcome. These methods would utilize correlation
between quality attributes, non-destructive measurements (such as spec-
troscopic techniques), the end product and raw or intermediate materials
(e.g. granules). In the optimal situation when PAT with QbD and RTR is
applied, the destructive testing could be totally avoided. All these tests are
specifically described in the European and United States Pharmacopoeias.
5.1 API concentration and content uniformity
The content uniformity refers to the API (active pharmaceutical ingredi-
ent, drug substance) content in the tablet and how much the content varies
between tablets. API content in tablets is one of the most critical quality
parameters (Skibsted et al. 2007) since it greatly affects drug release and
potency of a medication (Cournoyer et al. 2008). In particular, the detection
of a potent API at very low concentrations, i.e. a dose of a fewmilligrams or
even less (Lewis et al. 2005) is a very critical task to ensure that the manu-
facturer maintains quality (Gowen et al. 2008). The acceptance limit for the
drug content in the individual dose must normally fall within ±5%, how-
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ever, these limits are dependent on the formulation and can be found case
by case in the European Pharmacopoeia. Heterogeneity of API in a tablet
is also an important quality issue since it affects the tablet’s properties, e.g.
dissolution (Roggo et al. 2005; Gendrin et al. 2008) and thus its quality.
The conventional way to test the content uniformity within a batch is
to take a small random portion of tablets (e.g. 10 units) from the produc-
tion line, for instance from the start, middle and end of the process (Ravn
et al. 2008) and these are typically analyzed by HPLC in a separate lab-
oratory (Skibsted et al. 2007; Sulub et al. 2008). This is destructive and
time-consuming, and in addition, the tablet batch cannot proceed to further
treatment, such as coating or packaging, before the tests are finished (Skib-
sted 2005; Skibsted et al. 2007), which can sometimes take days, even weeks
(Sulub et al. 2008). It is noted that also the excipient(s) concentration within
the tablet formulation has to be taken into account since the complete char-
acterization of formulation cannot be fulfilled by detecting API concentra-
tion only (Wu et al. 2008). This situation could be made less cumbersome if
spectroscopic data could be acquired and analyzed with multivariate data
analysis (Cournoyer et al. 2008).
5.1.1 NIR as an X matrix in API testing
Reliable non-destructive tests need to be developed for API content deter-
mination for final tablets. Models and methods need to be validated, so
that they are sufficiently robust for use on a daily basis, repeatable, inde-
pendent of the analyst and provide accurate results (Tabasi et al. 2008).
NIR with PCA, MLR (multiple linear regression) and PLS have been uti-
lized to assess the API content in direct compressed (Tabasi et al. 2008) and
wet-granulated tablets (Skibsted et al. 2007) and tablets consisting of API
pellets (Gottfries et al. 1996). Tabasi et al. (2008) implemented a PLS model
betweenNIR andAPI content and themethodwas statistically evaluated as
being able to provide as accurate predictions as the UV method, i.e. within
±5%. acceptance limit. Gottfries et al. (1996) were able to construct a PLS
model utilizing NIR transmission data that predicted the API concentration
within tablets. The PLS model was able to capture variation of water con-
tent and thickness of the tablets and performed accurate predictions with a
prediction error of ±2% in relation to the average API content in samples.
Blanco et al. (2006) developed a PLS model with laboratory-made samples
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to predict the API content of commercial tablets. The prerequisite for a
good model is that both the calibration and test sets must span the same la-
tent variable space. Thus, the preparation conditions for laboratory-made
samples mimicked production conditions, i.e. samples were prepared un-
der similar tablet compression forces (Blanco and Alcala 2006; Blanco et al.
2006). The models of the first study were calibrated using laboratory-made
powder and tablet samples and tablets from production with good mod-
elling ability (Blanco and Alcala 2006). The second model consisted only
of laboratory made tablets in which there was extensive variation both in
API content and compression force and the technique succeeded in predict-
ing API with an accuracy of ±5% compared to results of HPLC reference
analysis.
Skibsted et al. (2007) predicted API content (for wet-granulated tablets)
utilizing PLS model and transmission NIR spectra from the wet-granulated
tablets. The model enabled the real time release (RTR) of the tablet prod-
uct. The PCA model they applied was able to differentiate tablets with dif-
ferent API contents. Moreover, the model showed also the differentiation
between the size of the batch from which the tablets had been processed
and it could identify the method that had been used. This finding indicates
that the scale of the production adds a variation source on the batches. Sar-
raguca and Lopes (2009) studied the feasibility to predict API and excipient
content in powder and tablet samples manufactured on a pilot-scale utiliz-
ing the PLS1 models with NIR in a lab-scale manufactured powder. The
study showed that the physical differences between samples, i.e. particle
size, manufactured in different sites which is present in the NIR data could
be minimized with pre-processing. Thus, using a calibration model with
lab-scale samples including intentional variations in the constituents could
be utilized for testing production scale samples which do not provide suf-
ficient variation in order to perform a robust model (Cogdill et al. 2005;
Sarraguca and Lopes 2009).
NIR and multivariate calibration methods have been applied for detec-
tion of tablets with low API content (Chalus et al. 2005; Alcala et al. 2008).
The study of Chalus et al. (2005) was conducted with 9 to 12 PLS compo-
nents which were determined as a minimum of SECV (standard error or
cross-validation) curve. The authors tested the model and claimed that it
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was accurate and repeatable and could be used as an alternative method to
traditional testing. Alcala et al. (2008) emphasized the importance of cali-
bration samples and proposed a method to select concentration ranges for
model calibration and implemented a multivariate detection and quantifi-
cation limits (MDL, MQL) for models. According to the MQL results, the
reduction of the upper concentration level in calibration enabled a more ac-
curate prediction for lowAPI contents. The artificial neural network (ANN)
model was developed to predict API. The model performance was evalu-
ated as being better than PLS at predicting the content of tablets with low
API content whereas an API content equal or more than 5% was more ac-
curately predicted by PLS (Chen et al. 2001). Certain wavelengths of NIR
were emphasized in ANN and they were found to correspond to the chem-
ical groups presented in API.
The PLS1 models have been constructed to analyze multiple compo-
nents in tablets with two API and three excipients (Cournoyer et al. 2008).
In this study, however, DoE was applied in order to attain calibration sam-
ples with none or minimal correlation between the constituents, since ac-
cording to the authors, a low correlation of constituents is needed in order
to achieve a good PLS model.
Sulub et al. (2008) mimicked PLS calibration transfer between develop-
ment and production sites using a primary NIR spectrometry and four sec-
ondary devices two of them being situated kilometres apart. The study
showed the feasibility of developing a transfer matrix between a local
model of primary instrument and others in order to minimize the response
variation and to estimate the content uniformity accurately regardless of
what kind of spectrometry was used. The purpose of transfer matrices is
to convert spectra acquired with other instruments into the same spectral
space attained from the primary instrument.
5.1.2 Raman as an X matrix in API testing
Johansson et al. (2005) utilized PLS for predictions of bothAPI and excipient
concentrations from Raman data. The study also examined sub-sampling
issues concerning effective sampling size, i.e, 0.4, 8, 16 and 39% of the
area of the tablet surface were illuminated with different patterns (point,
small and large circle and round area pattern, respectively) and compared
in terms of accuracy and repeatability. PLS performed the most accurate
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predictions with RMSEP of 1.7% compared to univariate techniques; fur-
thermore round area (39%) as well as a large circle (16%) were found to be
the most representative sampling areas.
5.1.3 Terahertz as an X matrix in API testing
More recently Terahertz spectroscopy with multivariate data analysis has
been also evaluated for detecting the API concentration as well as the
amounts of excipients in direct compressed andwet granulated tablets (Wu
et al. 2008). The feasibility study illustrated the superiority of multivariate
methods (PLS 1, PCR) over the univariate techniques (i.e. characteristic
peak maxima and superimposition method) to estimate different formula-
tion constituents, except for magnesium stearate that is a very low fraction
of the tablet. However, themethod as such requires sample preparation and
thus, cannot be considered as a non-invasive PAT method, instead it may
be used as a supplemental or compensatory method in the wet chemistry.
5.1.4 Chemical imaging and multivariate applications in
API testing
NIR, Raman and FTIR chemical imaging (CI) analysis in conjunction with
chemometrics have been utilized for the detection of API as well as excip-
ient concentrations in tablets (Clarke 2004; Zhang et al. 2005; Chan et al.
2005; Gendrin et al. 2007; Ravn et al. 2008; Amigo and Ravn 2009; Vajna
et al. 2010). Chemical imaging of the system allows detection of the spa-
tial distribution of different chemical constituents even if they are present
at very low concentrations (Gowen et al. 2008; Sasic 2007). One of the ear-
liest study with multivariate analysis applied on hyper-spectral images in
the field of pharmaceutical tablet was conducted by Clarke (2004). Clarke
(2004) applied PCA and PLS for images and evaluated process behavior
and cluster sizes of constituents from score images constructed using PCA
and PLS. Comparisons between different chemometrics methods for hyper-
spectral imaging of tablets have been conducted (Gendrin et al. 2007; Ravn
et al. 2008; Amigo and Ravn 2009). Gendrin et al. (2007) studied the util-
ity of hyperspectral imaging with PLS2 and CLS (classical least squares,a
model construction described in the publication of de Juan et al. (2004)) to
quantify API and other tablet constituents by averaging the predictions of
each pixel. Both methods, with and without model calibration, provided
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accurate API predictions, however, PLS2 was the only method to provide
accurate results about all constituents. Ravn et al. (2008) evaluated PLS1,
CLS and univariate wavenumber regression to predict the overall concen-
trations and distribution of three major tableting constituents out of five,
i.e. two excipients and API. PLS1 provided the most accurate predictions
although all methods were suitable for handling the hyper-spectral images.
One drawback of the PLSmethod is that it requires a calibration set which is
not always available (Zhang et al. 2005; Gendrin et al. 2007; Ravn et al. 2008;
Amigo and Ravn 2009). Amigo and Ravn (2009) employed CLS,MCR (mul-
tivariate curve resolution) and augmented MCR with NIR-CI to predict all
five tablet constituents without a calibration step and also to evaluate sam-
ple homogeneity. CLS and MCR performed well but failed to predict the
components at the smallest nominal concentrations due to a lack of selec-
tivity, i.e. pure spectra were highly correlated and formed a non-full rank.
The augmented version of MCR, where the full-rank or standard image had
been added to the analysis, achieved good predictions for all components
and depiction of spatial distribution over the pixels.
In the study of de Juan et al. (2004) Raman images of tablets with 0, 20,
40, 60 and 80% of API were analyzed using Fixed Size Moving Window-
Evolving Factor Analysis (FSMW-EFA). The method provided local rank
maps which could detect small regions (2 x 2 pixels) of heterogeneity, i.e.
heterogeneity between pixel-to-pixel. The rank one regions were either
constructed with one chemical constituents or had a constant composition.
Zhang et al. (2005) applied Raman image mapping to tablets and evaluated
clustering, CLS, PCA and MCR methods in terms of data processing. All
methods provided fairly comparable images with respect to the three main
constituents, however, CLS was considered as being the most reliable since
it was the only method based on a priori information, i.e. pure spectra. Sa-
sic (2007) applied Raman mapping for commercial tablets having low API
concentrations (0.5 mg and 1.0 mg of API). Raman signals were pre-treated
with PCA filtering since API could not be detected using raw data. The
study highlighted the feasibility of quantifying the API content from bina-
rized Raman score imaging. However, care must be taken to set thresh-
old limits in the binarization. Vajna et al. (2010) applied Raman imaging
for tablets that were either direct compressed, high shear or fluidized bed
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granulated and compared manufacturing methods according to the CLS
processed score images. The study showed that API was distributed spa-
tially differently in the tablet, depending on the manufacturing method.
FTIR-imaging feasibility study of Chan et al. (2005) acquired spectra
from three miniature size of tablets (weighing ca. 10 mg) compacted in a
special device with the ATR diamond being (at) the bottom of the die, in
situ. CLS was exploited to resolve the data cube into spectral and concen-
tration loadings corresponding to components (API and excipient). in this
way, the component concentrations and spatial distribution could be estab-
lished.
5.1.5 Multi-way applications in API testing
In addition to two-way methods, three-way calibration for API content
from NIR (Alcala et al. 2009) and fluorescence excitation-emission matrix
(EEM) (da Silva et al. 2002) data have been utilized, the latter being ap-
plied in the evaluation of a tablet solution. Alcala et al. (2009) decomposed
a three-way PARAFAC model with the first mode having tablets of differ-
ent API concentration, the second mode of NIR spectra and the third mode
of different compression force levels. The loadings of the first mode were
correlated with known nominal API concentrations within the tablets. The
PARAFAC model performed better compared to the unfolded PLS model
which was not capable of predicting API concentration of tablets com-
pressed at different forces since compression force and concentration vari-
ation are known to affect the NIR signal (Blanco and Alcala 2006; Blanco
et al. 2006; Alcala et al. 2009) and this was not captured by bilinear model.
On the contrary, PARAFAC decomposed the physical (compression force)
and chemical (API) information from NIR spectra with different modes in
a meaningful way.
5.2 Dissolution tests
The in vitro dissolution testing is the standard and the primary method
used to ensure functionality and similarity of tablets in a batch and between
batches. In this test, the concentration of the drug is detected as a function
of time in the liquid dissolution medium (Ferraro et al. 2003; Costa et al.
2003; Adams et al. 2001). The amount of dissolved API is detected using a
UV spectrophotometer or HPLC but the UV method may suffer from prob-
68
lems with detection, due to the non-selective nature of detection (Wiberg
and Hultin 2006; Gray et al. 2009). However, applications have been pro-
posed to detect dissolution characteristics of two or three API component
mixture of tablets with PLS1 utilizing a range of UV-vis spectra with over-
lapping peaks instead of one characteristic wavelength (Ferraro et al. 2003;
Dinc et al. 2003; Markopoulou et al. 2005).
Two widely utilized methods approved by the authorities are available
for dissolution testing; 1) the tablet is either set in a metal grid, e.g. a bas-
ket which is rotating (USP 1) or 2) the tablet is placed atthe bottom of the
dissolution vessel with the paddle rotating at the top of the vessel (USP
2). The tablet dissolution test is one of the most important in vitro tests for
drug bioavailability (Dokoumetzidis and Macheras 2006). However, the
dissolution methodology is a very simplified environment compared to the
human gastrointestinal tract and thus its relevance for extrapolating to the
in vivo situation can be questioned (Dokoumetzidis and Macheras 2006;
Gray et al. 2009). The tests provide, however, information about the dis-
solution mechanism, batch-to-batch consistency, critical process variables
and the reproducibility of drug release for formulation development; these
are important parameters for assessing tablet quality both immediately af-
ter manufacturing and during its shelf life (Graffner 2006; Gray et al. 2009).
However, these kinds of tests are time-consuming, destructive and prone to
interference andmeasurement variation (Gray 2006) thus there is a need for
an alternative method. In addition, discussion about dissolution methodol-
ogy inconsistencies such as between USP 1 & 2 and hydrodynamics (Baxter
et al. 2005; Pajander et al. 2008), and sampling issues (Baxter et al. 2005;
Paakkunainen et al. 2009) that give rise to variability in the test results,
have been highlighted recently (Gray et al. 2009). If reliable predictions
of dissolution behavior can be performed e.g. by monitoring and testing
critical quality attributes within a design space, the dissolution test may be
replaced by real time release (RTR) (Tong et al. 2007).
Next, novel methods based on chemometrics for dissolution tests will
be reviewed.
5.2.1 Prediction of dissolution profiles
Non-destructivemethods, e.g. NIR, are predicted to replace destructive dis-
solution test (Gray August 2004) mainly in conjunction with the PLS anal-
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ysis and there are indeed many NIR applications being utilized to assess
dissolution behavior (Donoso and Ghaly 2004; Freitas et al. 2005; Tatavarti
et al. 2005; Blanco et al. 2006; Otsuka et al. 2007). Bi-linear methods are
mainly utilized in the data analysis.
Freitas et al. (2005) acquired spectra from tablets with varying excipient
concentrations with the diffuse reflectance mode of NIR and established
the PLS model with the Y matrix consisting of percentages of dissolved
API as a function of time. The model was calibrated with 30 samples (three
tablets per batch, with the samples being dissolved at three different pH
values) resulting in a 10 component model and validated using LOO cross-
validation (internal validation) and external validation by leaving one batch
out of the modelling. The conclusions were that NIR and multivariate data
analysis provided adequate alternatives to conventional dissolution test-
ing. Tatavarti et al. (2005) made similar conclusions when they predicted
Q60 and Q120 (the percentage of dissolved API at times 60 and 120 minutes,
respectively) using NIR and PLS. Blanco et al. (2006) utilized the PLS cali-
bration model for determining API dissolution profiles using NIR data ac-
quired in the reflectance mode from intact laboratory-made tablets with dif-
ferent porosities. The Y matrix consisted of the percent of API dissolved at
the 30 min time point. The model was tested using commercially produced
tablets where reference analysis and PLS estimation provided comparable
results. Since the good quality of the conventional immediate release tablets
requires that 80% of API is dissolved by a time of 30 min, a PLS-DA model
was constructed to predict if tablets would meet this specification. It was
found that all production tablets did meet this specification. Otsuka et al.
(2007) applied a PCRmodel on NIR data on tablets with different porosities
with Ymatrix of time required for 75% dissolution (T75) and mean dissolu-
tion time (MDT). In order to perform a good model the Xmatrix needed to
include information related to dissolution behavior. The loadings seemed
to capture and were related to porosity and pore volume variation which
have a major impact on API dissolution.
NIR has certainly rich with chemical and physical contents. It contains
information about tablet porosity which has a major impact on drug disso-
lution (Donoso and Ghaly 2004). However, NIR acquired from intact tablet
does not contain interaction terms between the chemical constituents such
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as API-excipient, solvent-API, excipient-excipient interactions which have
also major effects on in vitro drug release (van Veen et al. 2005; Pajander
et al. 2009). In particular this is important if drug release of several differ-
ent APIs is being evaluated. In the study of Korhonen et al. (2005), molec-
ular descriptors were used to characterize the molecular level interactions
occurring during drug dissolution in conjunction with process parameters.
PLS was utilized to predict dissolution for multiple different drug formu-
lations and to explain cause and causality relationships. Recently, Huang
et al. (2009) utilized all processing and material parameters of 13 different
DoE batches to develop a dissolution model using PLS in order to assess
the most important parameters related to dissolution. The process param-
eters of granulation and compaction unit operations were used as well as
material attributes from intermediate phases. The variables from different
phases were assessed as being the most important, such as particle size, wet
massing time and amount of water and compaction force.
Multi-way methods, namely PARAFAC, have been applied for decom-
position of dissolution rate profiles of several experiments for tablets en-
closed in hard gelatin capsules with two API concentrations (Wiberg and
Hultin 2006). The first mode of the three-way array was the samples, the
second was the UV spectra and the third dissolution time. The presence
of gelatin capsule interfered the API UV-vis spectrum which, however, did
not interfere PARAFAC analysis that could estimate well both the release
profiles of API and excipient, their respective pure spectra and concentra-
tions. However, Rajko et al. (2009) questioned the use of PARAFAC for
analyzing dissolution data since rate profiles of constituents change from
sample to sample and thus do not fulfil the required trilinearity condition
of PARAFAC.
5.2.2 Comparison of dissolution profiles
After dissolution profile determination or prediction, the profile similar-
ity needs to be specified in the terms of quality control. A similar disso-
lution profile compared to the reference sample is one quality indicator
to demonstrate that the batch is acceptable and to monitor batch-to-batch
consistency. The release profile comparison is traditionally obtained using
methods such as ratio tests, difference ( f1) and similarity factors ( f2) tests,
statistical (nonlinear) mixed effect models or one-way or multivariate anal-
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ysis of variance (ANOVA and MANOVA, respectively) (Costa et al. 2001;
Graffner 2006). FDA (U.S. Food and Drug Administration) and EMEA (Eu-
ropean Medicines Agency) have approved the pair-wise similarity tests ( f1,
f2) for comparison of dissolution profiles, preferably f2 (O’Hara et al. 1998),
as is described in Eq. 5.1 (Costa et al. 2001).
f2 = 50×

[
1+
(
1
n
n
∑
j=1
|Rj − Tj|2
)]−0.5 (5.1)
where Tj and Rj are the percent dissolved in each sampling point n of
test and reference product, respectively and n represent the time points of
dissolution profiles. According to the FDA, if f2 is between 50 and 100, the
dissolution profiles are considered as being similar. However, the similar-
ity test based on f2 has faced some criticism concerning its scientific basis
(Costa et al. 2001). For instance, it does not take into account either the
shape of the dissolution profiles (Costa et al. 2001; Adams et al. 2001), or
any variability and correlation structure (O’Hara et al. 1998; Adams et al.
2001) and thus can lead false conclusions about similarity.
Adams et al. (2001) proposed an alternative method using PCA for de-
termining similarity between the dissolution profiles of test and reference
tablets. The PC based similarity model was able to detect both similar pro-
files and the outlying observations. The outlying dissolution profiles dif-
fered either along the first (PC 1) or second (PC 2) axes corresponding to the
level and shape of the dissolution profiles, respectively. Subsequently Mag-
gio et al. (2008) utilized a similar modelling approach to compare dissolu-
tion profiles of tablets with the same API formulation but different brands.
Hotelling’ s T2 statistics provided an arbitrary similarity limit of 80% for
comparison of dissolution. Profiles inside the 80% confidence interval cor-
responded to batches of similar qualities.
Roggo et al. (2005) constructed a PCA model that could differentiate
between tablets with bad and good dissolution behaviors thus enabling
the detection of samples out of specification. The parameters used in the
model were first derivative spectra of transmittance NIR of tablets. Tablets
with bad dissolution properties had a longer melt granulation time and
an increased compaction force had been used and in that way, they dis-
played decreased API particle size as well as slower dissolution. Recently,
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Paakkunainen et al. (2009) showed that a careful optimization strategy of
the whole tableting process could prevent tablet-to-tablet variation in dis-
solution properties.
5.3 Mechanical testing; crushing strength tests
and disintegration
Tablets need to stand the stress of packaging, transfer and storage (Alder-
born 2002). In order to test this property so-called friability and crushing
or mechanical strength tests need to be carried out according to USP guide-
lines. These tests provide physical information of tablets by mimicking the
conditions to which tablets may be subjected during down stream process-
ing (friability test) and how the tablet can resist the mechanical forces to
which it will be subjected (crushing strength). The friability test is con-
ducted by either shaking or rotating the tablet for a predetermined time
and subsequent measuring the weight loss after the test. Crushing strength
testing is carried out by compressing intact tablet with punches at a certain
force either in the lateral or vertical directions until the tablet break. These
tests destroy the tablet totally and therefore, they are not suitable tests for
large number of samples (Lewis et al. 2005). Moreover, concerns have been
raised about the accurate representation of a batch being evaluated and op-
erator errors can occur (Morisseau and Rhodes 1997; Kirsch and Drennen
1999). It should be noted, that tablet compression force is generally directly
linked to hardness and strength, however, the applicability is always case
dependent.
Several studies have established the relationship between NIR spec-
tra and physical information such as tablet hardness, i.e. by examining
tablets compressed with varying forces (Gottfries et al. 1996; Morisseau
and Rhodes 1997; Roggo et al. 2005; Blanco and Alcala 2006; Blanco et al.
2006; Otsuka et al. 2007; Tabasi et al. 2008; Alcala et al. 2009; Sarraguca and
Lopes 2009). In these studies, chemical information in NIR is the interesting
factor and the physical effect is an interferent, thus it is removed using pre-
processing methods such as the standard normal variate (SNV), multiplica-
tive scatter correction (MSC) and derivatives (Short et al. 2009). Therefore,
it is quite straightforward in the context of tablet mechanical properties to
take advantage of this ’interference’ and to establish a model between NIR
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and tablet hardness without needing to resort to conventional destructive
methods. However, a non-destructive test needs to be validated properly
to ensure its robustness, repeatibility and accuracy.
5.3.1 NIR as an X in mechanical testing
NIR is far and away the most widely applied data acquiring method in
hardness analysis of intact tablets. The earliest applications of chemometric
determination of relationship between NIR and tablet hardness were es-
tablished at the turn of this century (Morisseau and Rhodes 1997; Kirsch
and Drennen 1999). Morisseau and Rhodes (1997) carefully optimized PLS
and MLR models that were evaluated by the comparison of standard er-
ror or estimation (SEE) and the standard error of the reference method. In
this way, the authors emphasized the basic principle of calibration, i.e., no
model is better than the reference method. The study proved the usability
of the methods as alternative hardness testing tools, though, with the lim-
iting factor of drug content dependence. Thereafter, Kirsch and Drennen
(1999) applied PCA and PCR analysis from NIR and tablet strength data.
In that study, a general model to predict tablet strengths across a range of
API contents was developed to some extent. Subsequently, Tatavarti et al.
(2005) established a PLS model with reasonably good predictive abilities
even though there were varying API levels in the samples. Untreated spec-
tra were utilized in the predictions since variation in baseline reflects vari-
ation in the crushing strength. On the contrary, Cogdill et al. (2005) applied
a combination of MSC and first derivative for pre-processing and asa re-
sult RMSEP values of the PLS model were pretty high. However, the error
introduced by the reference method was almost equally large, manifesting
the error source of the reference analysis. Later, Short et al. (2009) acquired
both reflectance and transmittance data from laboratory made samples and
constructed PLS models. In order to show that spectral treatments such as
SNV and derivatives could remove the unwanted scatter effect in NIR, a
few PLS models with poor performances were established. The best mod-
els required mean centering of spectra and autoscaling of the response. The
minimum of RMSECV as a function of latent variables determined the com-
plexity of the model.
Artificial neural networks (ANN) have also been used to predict tablet
hardness with a range of differet API contents (Chen et al. 2001). Chen et al.
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(2001) compared the ANN and PLS methods in estimation of tablet hard-
ness and the ANN method was evaluated to exhibit better predictive abil-
ities over PLS. The optimum ANN model was the one with the minimum
sum of squared error values. The input strengths of the model revealed all
of the wavelengths which were important for model. Thus tablet strength
is a physical property not characterized by any particular wavelength as
noted many times earlier.
5.3.2 Raman as an X matrix in mechanical testing
Raman spectra contain also physical information just as NIR since the base-
line of raw spectra changes as a function of tablet crushing strength (Virta-
nen et al. 2008) and a few applications conducted by chemometric analysis
have been published. Therefore, Raman spectroscopy utilied in the chemo-
metric analysis can offer an alternative PAT tool for tablet testing.
Shah et al. (2007) constructed predictive PLS models with untreated Ra-
man data scanned from direct compressed and wet-granulated tablets, re-
spectively. According to these authors, the complexity of the model was
optimum when root mean squared error of calibration (RMSEC) and pre-
dictions (RMSEP) were small and nearly the same. Virtanen et al. (2008)
predicted tablet crushing strength from the corresponding Raman spectra
also by using PLS. Prior modelling, spectra were scaled to unit variance,
since most of the typically used pre-processing methods would eliminate
the baseline variation. The model performance was evaluated by inspect-
ing R2 and Q2 values and residuals. The PLS model error resembled the
reference method error.
5.3.3 Predictions across one of the previous unit operations
Tablet hardness has been predicted from outcome of the preceding unit op-
erations (in contrast to determination from intact tablets), such as granula-
tion (Luukkonen et al. 2008) and mixing (Otsuka and Yamane 2006, 2009).
This kind of prediction forms a key element of QbD where conditions of
unit operations are linked to the end product quality, enabling real-time
release of the product.
Otsuka and Yamane (2006) measured NIR spectra from powder mix-
tures processed with different lubricant (magnesium stearate) mixing times
prior to compression and used this data as an X matrix in the PCR anal-
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ysis. Variation of raw spectra was observed between the different pro-
cess conditions, i.e. tablet hardness decreased with increasing mixing time.
The regression vector represented the scientific basis for the analysis, i.e.,
there was a positive correlation of hydrogen groups on the hardness value
whereas there was a negative impact of the lubricant magnesium stearate
on strength. Magnesium stearate is known to affect mechanical strength
of a tablet since it may change material properties and interparticle bond-
ing (Wargo and Drennen 1996; Zuurman et al. 1999). Hydrogen bonding
in addition to van der Waals forces, is one of the strongest molecular level
interactions and is known to be linked to tablet strength.
NIR measurements performed during high-shear wet granulation were
successfully utilized as independent variables in multivariate and multi-
way predictions of tablet hardness (Luukkonen et al. 2008). The goal of this
study was to reveal the relationship between granule properties signalling
by NIR (Rantanen et al. 2005) and tablet quality. PLS and N-PLS were
applied to data, i.e. the last NIR spectrum of the granulation process was
utilized in PLS whereas all obtaned spectra during the course of the process
were exploited in N-PLS, the latter having batches in one of the modes of
the 3-way X array (Luukkonen et al. 2008). Prior analysis spectra were
centered. The explained variances of Y by the PLS and N-PLS models were
reported as being 92% and 94%, respectively.
5.3.4 Predictions across several unit operations and feed-
forward control schemes
Westerhuis et al. (1997) considered tablet manufacturing with a granulation
step as a two-step process (Fig. 5.1), i.e. first granulating the powder blend
and subsequently tableting. They utilized the process information of sev-
eral units in order to a) optimize and b) predict the end product, i.e. the
tablet quality, in terms of crushing strength and disintegration time. Two
PLSmodels were constructed; model 1 captured the blend composition and
process variables between unit operations and model 2 captured the same
as model 1 and also granule properties. Since physical granule properties
are highly collinear and also dependent on previous process step, the use
of PLS for prediction was justified. Model 1 was intended for finding pro-
cess variable settings if, for instance, the amount of a blend constituent was
changed. Model 2 was aimed for routine use to estimate tablet quality dur-
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Figure 5.1: Illustration of two-step tableting process. PV1 and PV2 denotes
process variables in the first and second steps, respectively. Adapted from
Westerhuis et al. (1997).
ing production since batch-to-batch variability of granules was taken into
account in the model. This model can be also used to help make adjust-
ments to process variables in order to ensure that the end product will be
able to meet its specifications. Westerhuis et al. (1997) also constructed a
control scheme as a result of certain estimated tablet quality parameters
(strength and disintegration) which differ from batch to batch. The control
scheme depicted estimated values as a function of two process parameters,
granule moisture content and compaction force for each batch according to
the predictions obtained with model 2.
Similarly, Skibsted et al. (2007) constructed PLS regression models be-
tween precending unit operations and final quality, i.e. the mean tablet
disintegration time, in order to demonstrate the benefits of a feed-forward
control system. The first model was designed with mixing time of raw con-
stituents, prior granulation (mix), three first PC scores of average NIR spec-
trum from mixing (NIR1∗ ) and granulation liquid flow (gra) (Fig. 5.2). The
second model comprised of variables used in the first model and the aver-
age three first scores of NIR spectrum of granulation (NIR2∗ ), the three first
scores of the last spectrum of drying (NIR3∗ ), the three first scores of the
average spectrum of lubricant mixing (NIR4∗ ) and process variables. The
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Figure 5.2: The unit operations (mix1,2, gra dry, tab) with NIR measure-
ments (NIR∗1,...,4) acquired post processing. The controlled variables were
mixTime refering to mixing time of dry powders, liqFlow refers to granula-
tion liquid flow, airT represents air temperature inside the granulator, dry-
Time is the drying time and punF is the average punch force in tableting.
The quality variable is disT which refers to the mean disintegration time of
tablet.
process variables were drying temperature (airT), drying time (dryTime)
and upper punch force of tableting (punF).
The first model can be applied for estimation of setting of granulation
liquid flow on the basis of the desired tablet disintegration time. This re-
quires hypothetical liquid flow values to be inserted into the model. The
second model could be utilized to estimate compression force equivalently.
However, rawmaterial variation was not included into the models of West-
erhuis et al. (1997) and Skibsted et al. (2007).
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6 AIMS OF THE STUDY
Themain thrust of this thesis was to explore the potential benefits of chemo-
metric methods that have been innovatively applied in the tableting manu-
facturing sub-processes of two-component matrix tablets. In the first part of
this study, the molecular descriptors with multivariate methods were uti-
lized as a potential tool for drug dissolution evaluation from the hydropho-
bic matrix tablet and the evaluation of drugs’ physicochemical properties.
In addition, the suitability of utilizing multi-way analysis for examining
spectral data acquired from tablets was evaluated.
In the second part of this research, multivariate and multi-way meth-
ods in conjunction with acoustic emission data and process variables from
granulation process of tableting material in fluidized bed granulation have
been exploited in order to enhance process understanding.
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7 CHEMOMETRICS AND TABLET QUALITY
I-III
These studies were conducted during the VARMA project years 2003–2007,
which aimed to develop a model that is able to predict all kinds of orally
administered drug release from the hydrophobic matrix tablet. The initial
way to accomplish this goal was to be able to explore as many orally active
drug compounds as possible (I). Next, the collected orally active compound
database was subjected to analysis with unsupervised clustering method
TS-SOM. The clustering of the chemical space of orally active compounds
was solely based on molecular descriptors characterizing the compound
properties. Next, one kind of Design of Experiments took place, i.e. a set
of physicochemically different drug compounds was chosen from different
regions of the map for further analysis. During the following years, these
compounds were subjected to tableting and to dissolution testing and in
spring 2007 an extensive set of dissolution profiles was acquired and an-
alyzed (II). The final chemometric analysis (II) required only one month,
whereas some of the experimental work took years. This project reveals
clearly how chemometric methods can aid and hasten the analysis time.
The study of the API content determination in matrix tablets (III) was
developed from the concept of utilizing multi-way methods on spectral
data (attenuated total reflection Fourier transform infrared ATR-FTIR) ac-
quired from tablets. The study was carried out in the years 2005–2006. Still
today fewmulti-way analysis have been conducted to evaluate tablet prop-
erties, thus this study (III), has novelty value. Next, the main results and
a very short introduction to the subject will be given. All data analyses
have been carried out using the commercial software package PLS_toolbox
(Eigenvector 2006) if not mentioned otherwise.
82
7.1 Chemical space of orally active compounds (I)
In this study, the chemical space of orally active compounds was explored
in order to select 15 compounds (II: Table 1) from different regions of space
for further processing. Chemical space consists of regions with drugs hav-
ing different properties, such as different biological activities. The selec-
tion of drugs for tableting and dissolution testing needs to encapsulate as
high variance as possible within the chemical space, that is spanned by the
variables relevantly describing the drug molecules. This is especially im-
portant if any general model is to be constructed or conclusions are to be
drawn on the basis of the selected drugs. Since chemical space is spanned
by several molecular variables (descriptors) related to drug properties and
these variables are most probably correlated to some extent, the selection of
the model drugs with high variance should not be based on separate vari-
ables (Westerhuis 1997). Instead, multivariate methods that encompass the
main variation within the data into lower dimensions should be used. Neu-
ral networks and clustering methods have proven to be tools for building
frames for previous conditions and distinguishing rather similar molecules
from others (Schneider 2000; Miller 2002).
Thus, in this work, the clustering was performed with TS-SOM (Visi-
point 2003) in which the clustering outcome depends on non-selective in-
put variables, meaning that no variables other than molecular level inter-
actions (VolSurf descriptor) were used in the training. VolSurf descriptors
are scalar values of physicochemical properties extracted from the 3D in-
teraction fields between target and probe molecules (Mannhold et al. 2006;
Cruciani et al. 2000; Crivori et al. 2000) (II: Table 2). The VolSurf descrip-
tors were computed using software version 4.1.4 (Molecular Discovery Ltd
2004). The goodness of clustering was generally assessed based on the def-
inition of chemical space, i.e.,the proper chemical space should be struc-
turally diverse (Manallack and Livingstone 1999) and contain regions with
drugs having the same activity.
As a result of this work, similar activities of drugs were located in
the same or neighboring neurons thus manifesting adequate clustering (II:
Table 2). Moreover, drugs located in distinct regions possessed different
physicochemical characteristics, such as different solubility and permeabil-
ity in biological fluids and membranes.
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Figure 7.1: Modelling procedure for dissolution profiles and compound
selection (I) for dissolution tests. the Ymatrix was dissolution data and the
Xmatrix molecular variables for test drugs and a few tableting parameters.
7.2 Estimation of dissolution profiles (II)
In the present study, the VolSurf molecular descriptors were innovatively
combined with a few tableting parameters to predict the drug release pro-
files (Fig. 7.1). VolSurf descriptors were also utilized to characterize the
large set of drug compounds by means of TS-SOMmapping (I), where a di-
verse test set for dissolution studies was selected. The dissolution of a drug
can be affected by many factors, such as drug solubility, the ratio between
drug and excipient, tablet geometry and porosity. Thus, in this study, we
assumed that if one has a constant drug load, the same excipient and tablets
compressed under similar conditions, the drug release phenomenon would
mostly be characterized by molecular level interactions and tablet proper-
ties.
Instead of using all dissolution time points (12 pcs), only 4 slopes de-
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Figure 7.2: The dissolution data (98 profiles) were split into 4 time intervals
and the slopes and the intercept were calculated. Once the variable selec-
tion was conducted, the PLS analysis was carried out for every response
(Y1 ... Y4).
rived from different phases of the dissolution curves were utilized in Y
(Fig. 7.2). This is feasible since slopes minimize the analytical error of the
dissolution method and estimate the continuous trend of the drug release
curve, which is not the case with the original dissolution values.
Separate PLS1 models were constructed having the Ymatrix as the com-
puted slope values. The model was able to differentiate release profiles for
different porosities (II: Figures 6 and 7) and provide meaningful informa-
tion about release phases at different time points (II: Figure 5). In addition,
themodel even predicted the rate and amount of drug release for a drug for-
mulation, which had not been introduced into the model previously. How-
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ever, there were issues with tablet homogeneity typical of matrix tablets
which could not be predicted by the model. Thus, it would be beneficial to
have a proper sampling plan, which would ensure better tablet homogene-
ity (Paakkunainen et al. 2009).
In conclusion, the model could be utilized as a feed-forward process
monitoring method, since hypothetical tableting values, i.e. compaction
forces and porosities could be inserted into the model and used to predict
the resulting dissolution profile. For instance, a similar control scheme was
presented by Westerhuis et al. (1997) which can be used to determine the
optimal compaction force values for new drug compound to obtain the
desired dissolution profile. It could be feasible to carry out similar mod-
elling studies in a pharmaceutical company, since most companies utilize
the same excipient(s) and technologies on a regular basis (Yu 2008).
7.3 Tablet quality (III)
The aim of the present studywas to build trilinear calibrationmodels and to
study their ability to predict the amount of drug compound in an axially cut
cylindrical starch acetate matrix tablet. The amounts of drug and excipient
were predicted from ATR-FTIR spectra using PARAFAC and N-PLS. Data
matrices consisted of dissolved and undissolved parallel samples having
different drug content and spectra, which were collected at the axially cut
surface of the flat-faced matrix tablets. Spectra were recorded comprehen-
sively at different points on the axially cut surface of the tablet (III: Figure
2). The sample drug concentrations varied between 2 to 16% V/V. Three-
way data array consisted of tablet samples of different drug loads in the
first mode, spectra in the second mode and sampling locations (i.e. repli-
cate measeures from different regions of tablet) in third mode, respectively.
In this study, the size of the three-way array was (6x1401x4). Thus,
the by-product of the second order advantage (Olivieri 2008) has been ex-
ploited since the calibration (and test) set included very few samples. In
addition, using only a few calibration samples is allowed when the con-
stituents in the samples are well-known and no unexpected interference
e.g. instrumental or new constituents (Martens and Martens 2001). Never-
theless, PARAFAC loadings coincided well with pure spectra of both con-
stituents (III: Figure 4 A), drug and excipient, despite the partial overlap-
ping of the spectra (III: Figure 3). Sample loadings depicted relative con-
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centration of constituents in samples (III: Figure 4 B). The third loadings,
which depicted sampling location on the tablet, i.e. a parallel measurement
point showed almost no variation with respect to the excipient concentra-
tion in tablet (III: Figure 4 C). Instead, drug concentrations do exhibit some
variation thus suggesting homogeneity issues with respect to the drug.
The multi-way methods together with ATR-FTIR spectra represented a
potential method for the determination of drug and excipient distribution
in the tablets. As a resultn N-PLS was more robust in terms of provid-
ing an accurate quantification of the amount of components in the sample
whereas the PARAFAC model provided approximate relative amounts of
components.
7.4 Summary (I–III)
The results show how bi-linear, multi-way and neural networks chemomet-
ric methods can be utilized to extract information from multivariate data
related to tableting unit operations ranging from pre-formulation studies
(I) to feed-forward controlling tool of tablet compression (II) and quality
testing (III).
I) This is the first time that unsupervised tree-structured self-organizing
map has been utilized for DoE purposes for evaluating a drug database
that included only compounds that were orally active or potentially orally
active drugs. The clustering showed physicochemically different drugs to
be located in distinct regions. The TS-SOM clustering is useful for visual-
ization of multidimensional (heterogenic) molecular data, e.g. data which
would need many principal components in order to accomplish the analy-
sis. However, TS-SOM cannot be used for reliable predictions since it lacks
the ability to save the initial model.
II) This is the first time that molecular modelling tools (molecular de-
scriptors) have been combinedwith pharmaceutical technological data (dis-
solution data) and utilized to perform quantitative model between drug
dissolution data (Y) and computed drug descriptors in conjunction with a
few tablet compaction parameters (X). The model enables a relatively rapid
estimation of the dissolution data of new drug molecules based on molec-
ular data and hypothetical tablet compression values. Even though the
model works well for drugs having an average release profile, it estimates
release profiles best in the model space. For instance, extreme release pro-
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files such as very slow or immediate release profiles may appear as outliers
in the model.
III) This is the first time thatmulti-way chemometricmethods have been
applied for tablet quality inspection by means of elucirating the API con-
tent uniformity (III). The model enabled the reliable prediction of the drug
in different locations of the tablet thus revealing potential heterogeneity re-
lated quality defects. The results indicated that by applying a multi-way
analysis method, reliable (good predictive ability) and meaningful (true
spectral loadings) models can be achieved with only a few calibration sam-
ples.
7.5 Perspectives
The studies (I-III) of this thesis represent valuable starting points for further
development of feed-forward control systems for the tablet compaction unit
operation and ultimately, real-time-release applications (RTR). The results
of studies (I-II) indicate that the combined TS-SOM - PLS method could be
applied for other kinds of matrix systems. The method presented in (II)
could be utilized as a process control or a development tool in the phar-
maceutical industry, e.g. for providing information about drug dissolu-
tion behaviour in the early phase of formulation studies. In the future, a
model (Matero et al. 2008) to distinguish the drugs which do not success-
fully form a stable matrix tablet together with starch acetate will be stud-
ied further. This will allow a better understanding of the physicochemical
nature of drugs in order to facilitate controlled release from hydrophobic
matrix tablets.
The current state of tablet quality research mainly involves studies of
API content in the tablets and univariate detection of other critical quality
attributes. In the future, tablet quality could be considered as a multivariate
property. For instance, quality matrix Y could be subjected to PCA and test
quality in a multivariate manner, or the NIR method and weight variation
test could replace unit dose content tests (ICH Q8(R2) 2009). According
to the literature review, chemical imaging (IC) techniques are emerging in
this field since e.g. NIR-CI provides both chemical and spatial information
about the active and inactive constituents in tablets (Ravn et al. 2008). For
instance, the studies of Sasic (2007) and Gowen et al. (2008) have demon-
strated the feasibility of using CI methods to detect API present at very low
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concentrations. However, images as well as any tableting unit operation,
will produce lots of data and these could be well processed with multivari-
ate analysis methods. Multivariate data analysis will soon be incorporated
to tablet development, manufacturing and quality testing during several
phases of pharmaceuticals production. Unfortunately, there are no guide-
lines to indicate which chemometric and measuring method would be ap-
propriate for a particular unit operation or CQA or details on how best to
perform the data analysis from different processes which rarely are similar
to another. This is due to the fact that alternative chemometric methods can
lead to a feasible solution. For instance, the modelling part of the study
(III) concerning API content in the tablets could have been carried out by
applying the PLS method.
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8 CHEMOMETRICS AND FLUIDIZED BED
GRANULATION IV-VI
These studies were carried out within the PATKIVA project years 2007–
2009. Here, the aimwas to develop a feed-forward process control for batch
fluidized bed granulation and to construct a model that could separate bad
batches from their well-performed counterparts. The strategy was to use
acoustic emission (AE) spectra and traditional process variables in analy-
sis in conjunction with chemometrics. In order to achieve this goal, certain
critical quality parameters need to be determined and these are followed,
predicted and assessed. In the first paper IV CQA’s were granule size and
water content and in the last two papers (V, VI) they were yield, i.e., gran-
ule size distribution. In paper V, the yield was determined post-process
whereas in paper VI granule size distributions were determined during
the process, i.e. different batches were carried out with a different process
length. Even though the feed-forward model was not able to be developed,
it was established that this model could separate batch quality from pro-
cess variables and also two feasibility studies were conducted with AE as a
measurement tool of the granulation process. In summary, the results high-
lighted the potential benefits of utilizing multivariate as well as multi-way
methods to study granulation.
Next, the main results and a very short introduction to the subject will
be presented. All data analyses have been carried out using the commercial
software package PLS_toolbox (Eigenvector 2006) if not mentioned other-
wise.
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8.1 Feasibility of acoustic emission for fluidized
bed granulation (IV)
Granule size and water content during granulation are of important
parametrs to be determined. In this study, the potential for using acoustic
emissions as a way of monitoring fluidized bed granulation was evaluated.
The basis of AE monitoring of fluidized bed granulation is that as granules
grow larger and the moisture content changes, their elastic properties also
changes and that also affects AE signals. In addition, other granule prop-
erties such as shape, hardness, porosity and uniformity of content affect
the signal. The relationship between granule properties and acoustical sig-
nals has not been unequivocally established since these attributes cannot
be measured directly. Instead, a regression model needs to be created, if
possible.
Two different case studies were provided. The purpose of the case 1
study was to develop a model for detecting and distinguishing qualita-
tively different sized pharmaceutical granules from acoustic emissions dur-
ing fluidization. In the case 2 study, a model was developed for quantifi-
cation of the bed moisture content during granulation. For these models,
data from process variables and AE signals within the frequency region of
50 - 625 kHz (IV: Figure 2 A) were combined using PLS and PCA. Gran-
ulations were performed with identical process settings, e.g. inlet air tem-
perature and humidity and formulation composition were constant. The
granule size and water content were determined during fluidization by a
thief probe and later in laboratory analysis. For the quantification models,
the information from the process parameters and acoustic emission data
were combined using PLS regression. During the modeling, the first two
minutes of process were excluded from the analysis since it was the mixing
time of mixture components and AE signals that differed greatly between
powder mixing and the wetting phase.
Themodels were able tomonitor the granule water content to be tracked
throughout the granulation process and granule size determination dur-
ing fluidization in most cases (IV: Figure 6). Thus, the multivariate meth-
ods were able to gather and extract physical information from the acoustic
emission spectra of fluidization and granulation. The relative humidity of
ambient air is crucial in determining the granule moisture and therefore
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it is important to stabilize its impact on the model and on batch-to-batch
variation. In addition, the AE measurement set-up need to be carefully val-
idated.
In order to minimize computing time for the AE signals and to simplify
the data handling, the spectra were pre-processed by averaging them into
segments (IV: Figure 2 B). Pre-processing was considered to be essential
for the good quality of the models and the averaging the spectra included
enough process information for the models. However, the problem remains
that one still cannot see inside the granulation process and therefore more
research needs to be done. Nonetheless, the results demonstrate that the AE
method is a very sensitive method for determining even the smallest gran-
ule sizes in powder blends, even under unusual process conditions, i.e. an
external material in the granulator (IV: Figure 7). Thus, the method is a
promising technique to be utilized as a process analytical tool for the phar-
maceutical industry since it provides useful information about the quality
attributes of fluidized bed granulation in real-time.
8.2 Multi-way models for fluidized bed granula-
tion process (V)
Pharmaceutical processes are typically run in the batch mode providing
a list of advantages, e.g. quality assurance of batch and disadvantages
(Leuenberger 2001a; Kourti 2009), such as batch-to-batch inconsistency. As
a simplification, one can state that understanding and controlling of gran-
ulation process is a black box. Its output is the knowledge of whether the
process has produced either good or bad quality granules. Thus, the objec-
tive here was to develop a model for differentiation of a successful quality
batch of fluidized bed granulation from unsuccessful batches where there
was a varied temporal duration between batches. Some of the batches were
deliberately over-wetted to induce bed collapse in order to obtain batch-
to-batch variance while other batches were run under normal conditions.
Here, the temperatures of the in- and outlet air and mass temperature were
utilized tomonitor the performance of different batch granulations. The flu-
idized bed granulation is a thermodynamic equilibrium process, and even
though the water vapour in inlet air has latent heat, which increases the
temperature of the wet granular mass to some extent, and the outlet air
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humidity is a direct indication on the extent of evaporation, we applied
a multi-way analysis on only the temperature variables. Nevertheless, the
batches with an appropriate granule distribution could be identified, which
indicated that the monitoring equipment and set-up can be simple and yet
offer a valid insight into the process.
Modelling was performed by PARAFAC and PARAFAC2. In their
comparison, the PARAFAC2 method provided a good differentiation be-
tween the successful and unsuccessful batches (V: Figure 7) whereas the
PARAFAC failed (V: Figure 5) due to the practical reasons inherent in the
method. In terms of process control purposes, the PARAFAC2 model en-
abled the evaluation of the goodness of the batch with different lengths of
processing, e.g. during the process run, by means of granule size distribu-
tion. However, the model limits do need to be established to define those
regions of the process phase that distinguish the unsuccessful batches from
good ones if real-time process control is the goal. In conclusion, the results
illustrated the well-known fact that the granulation process utilized in the
pharmaceutical industry is a complex process, which is often difficult to
model. However, the use of multi-way methods made it possible to obtain
information that enhanced the understanding of the process.
However, it should be noted that initially, PLS and PCA modeling were
tried but due to failure of modelling, the results were not published. Thus
for granulation process data, the best models were those performed using
multi-way methods. This was most probably due to the three-way nature
of the process data and batch-to-batch variation that could not be captured
using bilinear modelling. In addition, if one thinks the definition of good
and bad quality batches, the definition would be that a good quality batch
consists of low variation of granule sizes whereas an unsuccessful batch
consists of fines and clumps (V: Figure 1). In other words, granule size
variation is one of the reasons for an unsuccessful batch. In this study, only
temperature variables (in- and outlet, and mass temperature, respectively)
were needed to provide information about quality content. It is widely
recognized that bed moisture, i.e. moisture conditions inside the granula-
tor, affect granule growth, since wet granulation is based on mass wetting
and kinetics. As an oversimplification, one can say that when conditions
are too dry, granules will not become larger whereas too moist conditions
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will induce bed collapse and the formation of clumps. However, it should
be noted that temperature is not the sole reason for poor batch quality. The
granule size properties are the sum of starting materials and nucleation size
distribution and processing conditions caused by multiple varying and in-
teracting process parameters.
8.3 N-PLS estimation of granule size distribution
(VI)
In this study, it was shown for the first time that the nucleation phase of
granulation can be detected using acoustic emission techniques and sec-
ondly the possibility to predict an end product granule size distribution
by means of acoustic emission measurement of the nucleation phase. The
end product granule size distribution was determined in the early phase
of granulation, based on the observation that the quality of the early phase
nucleation strongly affected the quality of the end product. In the quantita-
tive model, the information gained from the process stream acquired with
an acoustic emission transducer was modeled using N-way PLS. The refer-
ence sieve analysis for the granule size distribution was performed off-line
and was used as the response variable. Since AE is influenced by the size of
the granules, and the acoustic signal is the sum of impacts of different size
granules, the AE signal could be expressed as a function of granule size
distribution (Fig. 8.1).
In order to predict the size distribution from non-selective AE signal,
one figure was needed to be created that describes (the shape of) the dis-
tribution. The 25% quartile of cumulative granule size distribution was
considered to be equivalent to the size distribution. Since the nuclei size
distribution was recognized as directly affecting the end product size distri-
bution, and because the elastic properties of the granules changed between
nucleation and steady growth regimes, the off-line analysis was based on
the acoustic data collected during nucleation only. In addition, a similar
analysis was performed on data collected during the steady growth phase,
and on data consisting of both the nucleation and steady growth phase from
the acoustic emissions to further emphasize the importance of identifying
the different growth regimes for process control.
Prior modelling, batch and AE modes were centered, which is the ac-
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Figure 8.1: The segmented AE signals by averaging the original signal
(left-hand side) can be expressed as the cumulative granule size distribu-
tion (right-hand side). The lateral solid line depicts the 25% quartile of the
cumulative sum, that is, the intersection of 25% and the cumulative sum
curve.
cepted way for multi-way models (Bro and Smilde 2003). The N-PLS mod-
els for different periods of granulation were calibrated. The three-way ar-
rays consisted of batch in the first mode, acoustic emission segments in the
secondmode and time in the thirdmode, respectively. The predicted versus
reference 25% quartile (f25%) values for test sets are illustrated in Figs. 8.2
and 8.3. The 25% quartile was the best for prediction of the granule size
distribution of the end product since it was the parameter which separated
best the successful from unsuccessful batches i.e. it encapulated informa-
tion about the size distribution. The result in Fig. 8.2 and 8.3 depicted how
modelling ability was decreasing after nucleation phase was detected. This
is understandable since the two overlapping phases, i.e. nucleation and
granule growth by collisions, could not be modelled together adequately.
If the phases are based on a different mechanism, they should be modelled
separately.
The model can be implemented into a process line. The ability to predict
the end product quality using acoustic emission measurement at the begin-
ning of the process, will notify the operators much earlier if a bad quality
batch is being produced. Thus, the operator is able to shut down the pro-
cess without losing more processing time and consequently, is able to save
money.
Still today, multi-waymodels inmanufacturing or development of phar-
95
Figure 8.2: The reference f25% values of calibaration samples versus the
predicted ones attained from the N-PLS calibration model (left-hand side)
and same for the test set (right-hand side). The calibration samples were
acquired within the time period of 60 – 450 sec of the process. RMSEP for
calibration set was 0.03.
maceutical solid dosage forms have not been extensively employed. This
work showed that utilizing a multi-way modelling may provide new in-
sights from the process and, capture the batch-to-batch variance which is a
major concern and uncontrollable factor in tablet unit processing.
8.4 Summary (IV–VI)
The results reveal that how multi-way methods (V, VI) are very suitable
for handling batch granulation data and better than bi-linear methods (IV),
since they are able to capture batch-to-batch variation which cannot be
achieved with two-waymethods. The studies provide one step on the route
towards the ultimate goal of coupling the information from multiple pro-
cess steps to achieve real time release of the product.
IV) This is the first time that bi-linear chemometric methods have been
utilized to extract information from acoustic emission data acquired during
fluidized bed granulation. The study showed that AE contains information
of granule size as well as the moisture content of granule mass and it can
be utilized as an Xmatrix in the predictive modelling. However, there were
some limits for predicting granule sizes fromAE spectra. In reality, if a mix-
ture of different granule sizes needs to be fluidized, the detected AE spectra
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Figure 8.3: The reference f25% values of test samples versus the predicted
ones attained from the N-PLS calibration models. The calibration samples
for models were acquired within a varying time period for each model, 60 –
750 sec of the process. RMSEPs for each calibration set were from left upper
corner to right lower corner 0.07, 0.08, 0.11, 0.17, 0.15 and 0.18.
will be the sum spectra of different size fractions in the powder mass. Thus,
the granule size predicted by any quantitive model, such as the PLS model,
will be the average of different sizes. This was demonstrated in this paper
by fluidizing a powder mixture which consisted of two component. More-
over, when the moisture content of granule mass was predicted, process
variables in conjunction with AE were needed in order build a model pro-
viding good predictivity.
V) This is the first time that a multi-way method has been utilized for
handling granulation process data. The model was able to distinguish
badly performed runs from the good runs utilizing only a few process pa-
rameters measured by default. The next step would be the construction of
the model capable of feed-forward control.
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VI) This is the first time that a multi-way calibration method has been
utilized to build a predictive model between the AE signal and the respec-
tive granule size distribution. The modelling procedure revealed the nucle-
ation end-point of granulation at the beginning of granulation which could
be utilized to predict the final granule size distribution. The modelling pro-
cedure showed that AE spectra is the sum of different granule sizes and
cannot be exploited to characterize of individual sizes of granules in the
real world. These findings are in accordance with the results of case study
1 in (IV)).
8.5 Perspectives
The goal of this project was to try to construct a feed-forward model for
granulation by utilizing acoustic emission data acquired from the process.
If one wishes to build a model for feed-forward control, certain process
parameters (e.g. temperature, liquid flow, droplet size) need to be incorpo-
rated into the modelling in order that the process conditions can be com-
pensated appropriately. Spectroscopic measurements, e.g. AE do not solely
provide a firm foundation for a feed-forward model since a spectroscopic
measurement of the process is unlikely to signal some critical process pa-
rameter (CPP). Thus, spectroscopic methods may only be used for predict-
ing critical quality attributes (CQAs) or establishing a multivariate finger-
print of the process in a design space (DS). Moreover, throughout these
studies many process parameters were kept constant and no DoE was ap-
plied. For example, this reduces the opportunities to find and estimate
an optimal combination of CPPs which will guarantee the desired prop-
erties in a batch of granules. If one wishes a reliable feed-forward control
scheme one also needs to incorporate raw material or input material vari-
ation into the model. For instance, information of input material can be
gathered through a spectroscopic scan or by doing an analysis in the labo-
ratory which is obviously more time demanding. Nonetheless, the studies
(IV-VI) provide valuable starting points for further development of control
systems for tableting unit operations and ultimately, for real time release
testing (RTR).
In general, nomultivariate applications are beingwidely applied among
granulation processing. However, multivariate methods can be applied not
only in process monitoring but also in basic research for revealing hidden
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information within the data generated. The studies (IV) and (VI) clearly
highlight this benefit. It is interesting that new and sophisticated spectro-
scopic techniques are constantly praised as potential PAT tools, but it is
often overlooked that there are other non-destructive measuring tools e.g.
thermometer. In study (V) this issue was addressed i.e. the basic process
parameters measured during granulation i.e. temperature of mass as well
as temperature of the in and outlet air may include information related to
CQAs when analyzed with an appropriate method. It would thus be ad-
vantageous to critically examine the limits of each non-invasive measuring
tool and to establish the best combination of tools providing information
of CQA to achieve the best understanding of process conditions. For in-
stance, the studies (IV) and (VI) indicate that AE can provide information
of granule size distribution and mean granule size, which are two CQA in
the granulation process, but it does not gather specific information about
different granule sizes. For example, it would be feasible to evaluate if AE
data would provide any clear benefit (other than a somewhat unique mea-
suring technique) to aid process understanding in preference to other spec-
troscopic instruments. AE data should also be analyzed more extensively
if it can provide any other details about the CQA of granules in addition to
size and moisture.
Since granulation processesmay be considered as a ’black-box’, it would
be advantageous to ’see’ inside the process e.g. using imaging techniques
such as chemical imaging (CI) which are an emerging field especially in API
content determination. One potential technique providing 3D information
of granulation process by permitting one to ’see’ inside the process could
be electrical capacitance tomography (ECT) which is a noninvasive and rel-
atively novel method. However, it should be noted that correct sampling
is still the major issue in all aspects of sample acquiring, and this needs to
receive more attention in the future. In summary, chemometric methods or
models are only as reliable as the data on which they are created.
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9 GENERAL CONCLUSIONS
PAT thinking and operating involves multivariate thinking, having chemo-
metrics as an integral part of the concept. Certain processes, e.g. tableting,
are multivariate in their very nature (Balboni 2003; Kourti 2006; Munson
et al. 2006) since they consist of several unit operations and produce multi-
variate data. Multivariate data needs to be analyzed with appropriate tools,
that is multivariate data analysis tools in chemometrics. Multivariate data
analysis provides an understanding of complex phenomena by discovering
relationships between measurements and in the best case, it can reveal the
reasons for certain process behaviors. For instance, multivariate calibra-
tion such as widely applied PLS enables "the development of mathematical
model relating unselective multiple instrumental signals with analyte con-
centrations (Olivieri 2008)".
In essence, the ideology behind PAT for tablet manufacturing is to
achieve 1) in-depth process understanding and 2) real-time process mon-
itoring via timely and non-destructive measurements from the process
stream. PAT is used for defining the process signature that enables themon-
itoring of the process and its state. By achieving real-time monitoring and
process knowledge, it is possible to detect possible failures early and, in
the best case scenario, to prevent the failures by compensating critical pro-
cess variables. This is because one can use multivariate models to detect if
samples are out of specifications and also to reveal the variable(s) that are
responsible for specific process behavior. There are several advantage to
using PAT framework e.g. fewer batch rejections, less labratory tests and
waste, deeper understanding of the process that is the ultimate prerequisite
for process control and real-time process state monitoring.
There has been a lot hype about PAT in tablet manufacturing for sev-
eral years. Nonetheless the literature reveals that the PAT applications are
mainly utilized for evaluation of one unit operation at a time and not for
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connecting all the operations via multivariate models. Moreover, the sit-
uation where process is carried out in terms of quality by design has not
yet conducted. If one considers PAT strategies, it is obvious that true pro-
cess control, which means that possible defects and process variation can
be compensated, has not yet being achieved, or at least the case studies are
not released in public. There are several reasons for this, such as inappro-
priate measuring devices, sampling problems and invalid analyzing (e.g.
univariate) methods. 1) Some unit operations are still very poorly under-
stood, such as complex granulation phase and they will need much more
basic research to unravel the relationships between process conditions, pro-
cessing material and end (or intermediate) product characteristics. 2) The
cultural and historical reasons should not be forgotten when considering
why the pharmaceutical industry lags far behind certain other industries,
e.g. food industry, with respect to process controlling. Pharmaceutical pro-
duction can be considered to be a very delicate nature of the chemical in-
dustry with its strict regulatory atmosphere (Cook 2007). Pharmaceuticals
have to be safe for human use and any changes concerning those processes
involve masses of paper work to be submitted to the authorities if changes
are being implemented because of the strict regulation in this field (Mun-
son et al. 2006). This, in particular is against real-time process control in-
troduced by the PAT guidance. 3) Finally, the most striking argument for
lack of ultimate PAT applications within tablet manufacturing is the inabil-
ity to see how chemometrics can be utilized, one could almost say that the
ignorance of chemometrics, which is in essence a major portion of PAT. This
is mainly due to lack of awareness of the power of chemometrics and due
to the blurred vision that chemometrics is a difficult and complicated sys-
tem involving mathematics and complicated calculations and the need for
sophisticated hardware (Workman 2002).
Despite the success of applying chemometrics within pharmaceutical
research, there are some drawbacks and concerns about the overall chemo-
metric approach. Firstly, many scientists are not yet ready to forego uni-
variate measurements and move towards a multivariate way of thinking.
Secondly, there is a major concern about the usage of chemometrics by in-
experienced scientists (Pretsch and Wilkins 2006) and the challenge of ex-
plaining the issues and concepts to non-chemometricians, e.g., creating a
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dialogue between process personnel and chemometricians (Miller 2005).
Perhaps one of the greatest challenges is to convince those individuals who
believe that only fundamental, theoretical, i.e. hard models, are the key to
success that data-driven methods, i.e., chemometrics methods, can do the
job just as well. Already in 1990 an article was published based on inter-
views of originators of chemometrics, where Prof. Bruce Kowalski specu-
lated whether there would be any equivalent chemometrics application in
physics, i.e. physiometrics or Physics-ometry, since "physicists can’t leave
theory" (Geladi and Esbensen 1990). Thus, we need more education and
knowledge within chemometrics and to demonstrate time and time again
that chemometrics actually works. All in all, the ultimate situation would
be that if one is confronted with the term ’chemometrics’, one should cat-
egorize it as one more scientific discipline just as one does with chemistry,
mathematics and physics.
Today tablets are being produced in a safe, accepted and validated man-
ner but monitoring is carried out in a univariate manner and control is
based on post-process quality checks. The end product analysis provides
almost no information about process itself, thus it adds nothing to process
understanding and this eliminates the possibility of fault diagnostics. In or-
der to fully understand the process (Cook 2007), it is understood when 1)
one can explain batch-to-batch variability, 2) can reliably predict if a batch
will be successful or not from the in-process data, and 3) all factors affect-
ing quality have been considered (Cook 2007). However, the PAT tools
may certainly improve process understanding and would be one step to-
wards safer products, consistent quality (Dziki 2008) and reduced costs.
In essence, chemometrics will be no doubt play a great role in tablet pro-
duction and also in basic research in the future. Nonetheless, it is unlikely
that traditional end product testing will ever be totally replaced by on-line
process control and predictive models.
Finally, a few ideas (some of them being addressed in theses of West-
erhuis (1997) and Skibsted (2005)) about how multivariate methods can be
applied to tableting in future
1) Tablet quality, as well as intermediate product quality, such as gran-
ules, could be considered as a multivariate property. For instance, quality
matrix Y could be subjected to e.g. PCA and test quality in a multivariate
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manner.
2) Multivariate models, e.g. latent variable models, could be utilized to
connect unit operations, since the end or the intermediate product is the
sum of the process events.
3) The pharmaceutical industry and related research laboratories could
adopt control strategies more efficiently and learn from other industries.
4) Raw material characterization e.g. with spectra should be included
in chemometrics models since raw material variation can lead to batch-to-
batch variation.
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The main goal of this thesis was to 
explore the tableting manufacturing 
sub-processes utilizing chemomet-
rics. In the first part of this study, 
the tablet quality was explored with 
multivariate methods. In the second 
part of this study, multi-way meth-
ods in conjunction with acoustic 
emission data and process variables 
from granulation process of tableting 
material in fluidized bed granula-
tion have been exploited. This thesis 
shows the feasibility and power of 
multivariate data analysis in case of 
evaluation of tablet development and 
manufacturing unit operations.
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